MetaADEDB 2.0 @ LMMD
Imatinib Mesylate
(YLMAHDNUQAMNNX-UHFFFAOYSA-N)
Structure
SMILES
CS(=O)(=O)O.CN1CCN(CC1)Cc1ccc(cc1)C(=O)Nc1ccc(c(c1)Nc1nccc(n1)c1cccnc1)C
Molecular Formula:
C30H35N7O4S
Molecular Weight:
589.708
Log P:
5.1969
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
3
TPSA:
149.03
CAS Number(s):
220127-57-1
Synonym(s)
1.
Imatinib Mesylate
2.
Alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide
3.
CGP 57148
4.
CGP-57148
5.
CGP57148B
6.
Gleevec
7.
Glivec
8.
Imatinib
9.
Imatinib Methanesulfonate
10.
ST 1571
11.
ST1571
12.
STI 571
13.
STI-571
14.
STI571
15.
CGP57148
16.
Mesylate, Imatinib
17.
Methanesulfonate, Imatinib
External Link(s)
MeSHD000068877
PubChem Compound90091706
123596
BindingDB86734
ChEBI31690
CHEMBLCHEMBL1642
KEGGdr:D01441
Therapeutic Target DatabaseD0Z6KI
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 1100
Canada Vigilance: 55
19849764CTD
Canada Vigilance
US FAERS
2Malignant neoplasm progressionFAERS: 875
Canada Vigilance: 44
Canada Vigilance
US FAERS
3MalaiseFAERS: 844
Canada Vigilance: 29
Canada Vigilance
US FAERS
4VomitingFAERS: 822
Canada Vigilance: 46
18409077CTD
Canada Vigilance
US FAERS
5FatigueFAERS: 711
Canada Vigilance: 46
Canada Vigilance
US FAERS
6Drug ineffectiveFAERS: 619
Canada Vigilance: 101
Canada Vigilance
US FAERS
7AstheniaFAERS: 511
Canada Vigilance: 22
Canada Vigilance
US FAERS
8PneumoniaFAERS: 480
Canada Vigilance: 6
Canada Vigilance
US FAERS
9Abdominal PainFAERS: 367
Canada Vigilance: 10
Canada Vigilance
US FAERS
10PainFAERS: 362
Canada Vigilance: 20
Canada Vigilance
US FAERS
11HeadacheFAERS: 357
Canada Vigilance: 10
Canada Vigilance
US FAERS
12White blood cell count decreasedFAERS: 340
Canada Vigilance: 3
Canada Vigilance
US FAERS
13ThrombocytopeniaFAERS: 295
Canada Vigilance: 6
Canada Vigilance
US FAERS
14ArthralgiaFAERS: 293
Canada Vigilance: 11
Canada Vigilance
US FAERS
15PancytopeniaFAERS: 275
Canada Vigilance: 5
Canada Vigilance
US FAERS
16DizzinessFAERS: 271
Canada Vigilance: 9
Canada Vigilance
US FAERS
17MyalgiaFAERS: 270
Canada Vigilance: 11
Canada Vigilance
US FAERS
18SepsisFAERS: 267
Canada Vigilance: 3
Canada Vigilance
US FAERS
19Cerebrovascular accidentFAERS: 265
Canada Vigilance: 4
Canada Vigilance
US FAERS
20Drug resistanceFAERS: 256
Canada Vigilance: 16
Canada Vigilance
US FAERS
21General physical health deteriorationFAERS: 241
Canada Vigilance: 4
Canada Vigilance
US FAERS
22PruritusFAERS: 217
Canada Vigilance: 8
Canada Vigilance
US FAERS
23Weight decreasedFAERS: 216
Canada Vigilance: 12
Canada Vigilance
US FAERS
24Myocardial InfarctionFAERS: 212
Canada Vigilance: 3
Canada Vigilance
US FAERS
25Abdominal discomfortFAERS: 207
Canada Vigilance: 16
Canada Vigilance
US FAERS
26Bone painFAERS: 205
Canada Vigilance: 9
Canada Vigilance
US FAERS
27Drug exposure during pregnancyFAERS: 201US FAERS
28NasopharyngitisFAERS: 201
Canada Vigilance: 6
Canada Vigilance
US FAERS
29Disease ProgressionFAERS: 196
Canada Vigilance: 5
Canada Vigilance
US FAERS
30NeutropeniaFAERS: 188
Canada Vigilance: 8
Canada Vigilance
US FAERS
31AscitesFAERS: 179
Canada Vigilance: 4
Canada Vigilance
US FAERS
32InfectionFAERS: 177
Canada Vigilance: 6
Canada Vigilance
US FAERS
33Back PainFAERS: 170
Canada Vigilance: 3
Canada Vigilance
US FAERS
34Feeling abnormalFAERS: 159
Canada Vigilance: 12
Canada Vigilance
US FAERS
35SplenomegalyFAERS: 156
Canada Vigilance: 1
Canada Vigilance
US FAERS
36Diabetes MellitusFAERS: 155US FAERS
37SwellingFAERS: 153
Canada Vigilance: 13
Canada Vigilance
US FAERS
38No adverse eventFAERS: 145US FAERS
39Chest PainFAERS: 141
Canada Vigilance: 5
Canada Vigilance
US FAERS
40Peripheral swellingFAERS: 139
Canada Vigilance: 8
Canada Vigilance
US FAERS
41AlopeciaFAERS: 131
Canada Vigilance: 4
Canada Vigilance
US FAERS
42Full blood count decreasedFAERS: 128
Canada Vigilance: 1
Canada Vigilance
US FAERS
43Blood creatinine increasedFAERS: 127
Canada Vigilance: 4
Canada Vigilance
US FAERS
44Therapy non-responderFAERS: 127
Canada Vigilance: 26
Canada Vigilance
US FAERS
45Maternal exposure during pregnancyFAERS: 121US FAERS
46HypersensitivityFAERS: 119
Canada Vigilance: 4
Canada Vigilance
US FAERS
47TuberculosisFAERS: 118US FAERS
48BlindnessFAERS: 117
Canada Vigilance: 6
Canada Vigilance
US FAERS
49NephrolithiasisFAERS: 112
Canada Vigilance: 3
Canada Vigilance
US FAERS
50Respiratory FailureFAERS: 108
Canada Vigilance: 1
Canada Vigilance
US FAERS
51Septic ShockFAERS: 105US FAERS
52Memory impairmentFAERS: 104
Canada Vigilance: 1
Canada Vigilance
US FAERS
53Urinary tract infectionFAERS: 104
Canada Vigilance: 3
Canada Vigilance
US FAERS
54DehydrationFAERS: 103
Canada Vigilance: 4
Canada Vigilance
US FAERS
55Alanine Aminotransferase IncreasedFAERS: 102
Canada Vigilance: 3
Canada Vigilance
US FAERS
56InfluenzaFAERS: 102
Canada Vigilance: 6
Canada Vigilance
US FAERS
57LeukocytosisFAERS: 102
Canada Vigilance: 3
Canada Vigilance
US FAERS
58Aspartate Aminotransferase IncreasedFAERS: 101
Canada Vigilance: 4
Canada Vigilance
US FAERS
59ConstipationFAERS: 101
Canada Vigilance: 5
Canada Vigilance
US FAERS
60Dry skinFAERS: 98
Canada Vigilance: 5
Canada Vigilance
US FAERS
61AmnesiaFAERS: 96
Canada Vigilance: 3
Canada Vigilance
US FAERS
62ErythemaFAERS: 94
Canada Vigilance: 4
Canada Vigilance
US FAERS
63LeukopeniaFAERS: 93
Canada Vigilance: 5
Canada Vigilance
US FAERS
64Pericardial effusionFAERS: 92
Canada Vigilance: 8
Canada Vigilance
US FAERS
65Joint swellingFAERS: 90
Canada Vigilance: 5
Canada Vigilance
US FAERS
66Visual ImpairmentFAERS: 88
Canada Vigilance: 1
Canada Vigilance
US FAERS
67DyspepsiaFAERS: 82
Canada Vigilance: 11
Canada Vigilance
US FAERS
68Chest discomfortFAERS: 78
Canada Vigilance: 5
Canada Vigilance
US FAERS
69HypotensionFAERS: 78
Canada Vigilance: 4
Canada Vigilance
US FAERS
70Neutrophil count decreasedFAERS: 78
Canada Vigilance: 3
Canada Vigilance
US FAERS
71Blood creatine phosphokinase increasedFAERS: 76
Canada Vigilance: 7
Canada Vigilance
US FAERS
72Product use issueFAERS: 76US FAERS
73Cytogenetic analysis abnormalFAERS: 75US FAERS
74Atrial FibrillationFAERS: 73
Canada Vigilance: 2
Canada Vigilance
US FAERS
75jaundiceFAERS: 73US FAERS
76AnxietyFAERS: 71
Canada Vigilance: 3
Canada Vigilance
US FAERS
77CholelithiasisFAERS: 71
Canada Vigilance: 3
Canada Vigilance
US FAERS
78LymphadenopathyFAERS: 71
Canada Vigilance: 2
Canada Vigilance
US FAERS
79Tumour haemorrhageFAERS: 69
Canada Vigilance: 2
Canada Vigilance
US FAERS
80DysgeusiaFAERS: 68
Canada Vigilance: 2
Canada Vigilance
US FAERS
81FlatulenceFAERS: 68
Canada Vigilance: 9
Canada Vigilance
US FAERS
82treatment failureFAERS: 68
Canada Vigilance: 3
Canada Vigilance
US FAERS
83DeafnessFAERS: 67
Canada Vigilance: 2
Canada Vigilance
US FAERS
84Disseminated Intravascular CoagulationFAERS: 67US FAERS
85Oropharyngeal painFAERS: 67
Canada Vigilance: 3
Canada Vigilance
US FAERS
86Blood alkaline phosphatase increasedFAERS: 66
Canada Vigilance: 1
Canada Vigilance
US FAERS
87DementiaFAERS: 66US FAERS
88MetastasisFAERS: 66
Canada Vigilance: 3
Canada Vigilance
US FAERS
89StressFAERS: 66
Canada Vigilance: 3
Canada Vigilance
US FAERS
90EpistaxisFAERS: 65
Canada Vigilance: 3
Canada Vigilance
US FAERS
91Sudden deathFAERS: 65US FAERS
92ArthritisFAERS: 64
Canada Vigilance: 6
Canada Vigilance
US FAERS
93Cerebral InfarctionFAERS: 64US FAERS
94BronchitisFAERS: 63US FAERS
95Gene mutation identification test positiveFAERS: 63
Canada Vigilance: 2
Canada Vigilance
US FAERS
96PalpitationsFAERS: 62
Canada Vigilance: 4
Canada Vigilance
US FAERS
97TremorFAERS: 62
Canada Vigilance: 3
Canada Vigilance
US FAERS
98PallorFAERS: 61
Canada Vigilance: 3
Canada Vigilance
US FAERS
99Skin lesionFAERS: 61
Canada Vigilance: 2
Canada Vigilance
US FAERS
100AsthmaFAERS: 60US FAERS
101Blood count abnormalFAERS: 59
Canada Vigilance: 3
Canada Vigilance
US FAERS
102Cardiac ArrestFAERS: 59
Canada Vigilance: 1
Canada Vigilance
US FAERS
103Intestinal ObstructionFAERS: 59
Canada Vigilance: 1
Canada Vigilance
US FAERS
104Blood lactate dehydrogenase increasedFAERS: 58
Canada Vigilance: 2
Canada Vigilance
US FAERS
105ChillsFAERS: 58
Canada Vigilance: 5
Canada Vigilance
US FAERS
106InflammationFAERS: 58US FAERS
107Febrile NeutropeniaFAERS: 57US FAERS
108Musculoskeletal PainFAERS: 57
Canada Vigilance: 4
Canada Vigilance
US FAERS
109Disease recurrenceFAERS: 56US FAERS
110ThrombosisFAERS: 56
Canada Vigilance: 1
Canada Vigilance
US FAERS
111SomnolenceFAERS: 55
Canada Vigilance: 3
Canada Vigilance
US FAERS
112DysuriaFAERS: 54
Canada Vigilance: 2
Canada Vigilance
US FAERS
113Pancreatic carcinomaFAERS: 53
Canada Vigilance: 1
Canada Vigilance
US FAERS
114UrticariaFAERS: 53
Canada Vigilance: 2
Canada Vigilance
US FAERS
115AnorexiaFAERS: 52US FAERS
116OsteoporosisFAERS: 52
Canada Vigilance: 3
Canada Vigilance
US FAERS
117AbasiaFAERS: 51US FAERS
118CataractFAERS: 51US FAERS
119DysphoniaFAERS: 51
Canada Vigilance: 2
Canada Vigilance
US FAERS
120MYELODYSPLASTIC SYNDROMEFAERS: 51US FAERS
121Post procedural complicationFAERS: 50
Canada Vigilance: 1
Canada Vigilance
US FAERS
122Blood glucose increasedFAERS: 49US FAERS
123GastritisFAERS: 47US FAERS
124Musculoskeletal stiffnessFAERS: 47
Canada Vigilance: 2
Canada Vigilance
US FAERS
125Pulmonary EmbolismFAERS: 47
Canada Vigilance: 1
Canada Vigilance
US FAERS
126Rash erythematousFAERS: 47
Canada Vigilance: 1
Canada Vigilance
US FAERS
127EosinophiliaFAERS: 4618409077CTD
US FAERS
128Exposure via fatherFAERS: 46
Canada Vigilance: 1
Canada Vigilance
US FAERS
129HepatomegalyFAERS: 45
Canada Vigilance: 1
Canada Vigilance
US FAERS
130DiscomfortFAERS: 44
Canada Vigilance: 3
Canada Vigilance
US FAERS
131Toxicity to various agentsFAERS: 44
Canada Vigilance: 2
Canada Vigilance
US FAERS
132Full blood count increasedFAERS: 43
Canada Vigilance: 1
Canada Vigilance
US FAERS
133Gamma-Glutamyltransferase IncreasedFAERS: 43US FAERS
134HepatotoxicityFAERS: 43
Canada Vigilance: 2
Canada Vigilance
US FAERS
135NervousnessFAERS: 43US FAERS
136Burning sensationFAERS: 42
Canada Vigilance: 5
Canada Vigilance
US FAERS
137StomatitisFAERS: 42
Canada Vigilance: 1
Canada Vigilance
US FAERS
138SyncopeFAERS: 42
Canada Vigilance: 4
Canada Vigilance
US FAERS
139EczemaFAERS: 41US FAERS
140Gastric Antral Vascular EctasiaFAERS: 41US FAERS
141WheezingFAERS: 41US FAERS
142Ejection Fraction DecreasedFAERS: 40
Canada Vigilance: 4
Canada Vigilance
US FAERS
143LymphomaFAERS: 40
Canada Vigilance: 4
Canada Vigilance
US FAERS
144MyelofibrosisFAERS: 39US FAERS
145Product use in unapproved indicationFAERS: 39US FAERS
146Respiratory distressFAERS: 39US FAERS
147Wrong technique in product usage processFAERS: 39
Canada Vigilance: 3
Canada Vigilance
US FAERS
148Dengue FeverFAERS: 38US FAERS
149GastrectomyFAERS: 38US FAERS
150TinnitusFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
151AphasiaFAERS: 37
Canada Vigilance: 2
Canada Vigilance
US FAERS
152CellulitisFAERS: 36
Canada Vigilance: 2
Canada Vigilance
US FAERS
153HepatitisFAERS: 36
Canada Vigilance: 2
12750713
15523233
16772838
CTD
Canada Vigilance
US FAERS
154Concomitant disease progressionFAERS: 35US FAERS
155Depressed moodFAERS: 34US FAERS
156DiverticulitisFAERS: 34
Canada Vigilance: 2
Canada Vigilance
US FAERS
157HaematotoxicityFAERS: 34US FAERS
158HypoxiaFAERS: 34
Canada Vigilance: 1
Canada Vigilance
US FAERS
159MalariaFAERS: 34US FAERS
160RhabdomyolysisFAERS: 34
Canada Vigilance: 2
Canada Vigilance
US FAERS
161SinusitisFAERS: 34
Canada Vigilance: 2
Canada Vigilance
US FAERS
162Squamous cell carcinomaFAERS: 34US FAERS
163Typhoid FeverFAERS: 34US FAERS
164LethargyFAERS: 33
Canada Vigilance: 4
Canada Vigilance
US FAERS
165VertigoFAERS: 33
Canada Vigilance: 3
Canada Vigilance
US FAERS
166ConjunctivitisFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
167GlaucomaFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
168HypophagiaFAERS: 32US FAERS
169HypothyroidismFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
170PancreatitisFAERS: 32US FAERS
171PeritonitisFAERS: 32US FAERS
172Productive CoughFAERS: 32US FAERS
173TachycardiaFAERS: 32
Canada Vigilance: 4
Canada Vigilance
US FAERS
174AbscessFAERS: 31
Canada Vigilance: 2
Canada Vigilance
US FAERS
175Blood potassium decreasedFAERS: 31
Canada Vigilance: 4
Canada Vigilance
US FAERS
176HerniaFAERS: 31US FAERS
177Limb injuryFAERS: 31US FAERS
178Night sweatsFAERS: 31
Canada Vigilance: 1
Canada Vigilance
US FAERS
179Product substitution issueFAERS: 31US FAERS
180Terminal stateFAERS: 31US FAERS
181Abdominal massFAERS: 30US FAERS
182Acute kidney injuryFAERS: 30
Canada Vigilance: 3
16288076CTD
Canada Vigilance
US FAERS
183Depressed Level of ConsciousnessFAERS: 30US FAERS
184NoduleFAERS: 30US FAERS
185PneumonitisFAERS: 30
Canada Vigilance: 3
Canada Vigilance
US FAERS
186Renal cystFAERS: 30
Canada Vigilance: 2
Canada Vigilance
US FAERS
187Coronary Artery DiseaseFAERS: 29
Canada Vigilance: 2
Canada Vigilance
US FAERS
188Drug dose omissionFAERS: 29US FAERS
189Macular degenerationFAERS: 29US FAERS
190Skin UlcerFAERS: 29US FAERS
191Transaminases increasedFAERS: 29US FAERS
192Transmission of drug via semenFAERS: 29US FAERS
193ColitisFAERS: 28US FAERS
194Concomitant disease aggravatedFAERS: 28US FAERS
195CytopeniaFAERS: 28US FAERS
196FractureFAERS: 28US FAERS
197Oncologic complicationFAERS: 28US FAERS
198ShockFAERS: 28US FAERS
199Altered state of consciousnessFAERS: 27US FAERS
200Angina PectorisFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
201Blood urea increasedFAERS: 27US FAERS
202DisorientationFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
203Neck PainFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
204Neutropenic sepsisFAERS: 27US FAERS
205AgranulocytosisFAERS: 26US FAERS
206Basal cell carcinomaFAERS: 26US FAERS
207Blood urine presentFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
208Completed SuicideFAERS: 26US FAERS
209Deep Vein ThrombosisFAERS: 26US FAERS
210IleusFAERS: 26US FAERS
211Oral painFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
212Acute myocardial infarctionFAERS: 25US FAERS
213Electrolyte imbalanceFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
214GangreneFAERS: 25US FAERS
215Growth retardationFAERS: 25
Canada Vigilance: 2
Canada Vigilance
US FAERS
216Peripheral arterial occlusive diseaseFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
217furuncleFAERS: 25US FAERS
218Blast cell count increasedFAERS: 24US FAERS
219Blood glucose decreasedFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
220Eye painFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
221Liver AbscessFAERS: 24US FAERS
222OsteomyelitisFAERS: 24US FAERS
223Feeling ColdFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
224Incorrect dose administeredFAERS: 23US FAERS
225Lipase increasedFAERS: 23US FAERS
226Multiple MyelomaFAERS: 23US FAERS
227Urinary RetentionFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
228Ankle FractureFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
229Hepatitis BFAERS: 22US FAERS
230PneumothoraxFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
231Pulmonary HypertensionFAERS: 22US FAERS
232ThrombocytosisFAERS: 22US FAERS
233UlcerFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
234AppendicitisFAERS: 21US FAERS
235CystitisFAERS: 21US FAERS
236CystFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
237GoutFAERS: 21US FAERS
238Hepatic necrosisFAERS: 21US FAERS
239MalnutritionFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
240NocturiaFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
241Pulmonary FibrosisFAERS: 21
Canada Vigilance: 1
17849262
29720568
CTD
Canada Vigilance
US FAERS
242Respiratory arrestFAERS: 21US FAERS
243Retinal DetachmentFAERS: 21US FAERS
244Stem cell transplantFAERS: 21US FAERS
245AcneFAERS: 20
Canada Vigilance: 3
Canada Vigilance
US FAERS
246CachexiaFAERS: 20US FAERS
247General physical condition abnormalFAERS: 20US FAERS
248PetechiaeFAERS: 20US FAERS
249Product quality issueFAERS: 20US FAERS
250ProteinuriaFAERS: 2019242505CTD
US FAERS
251White blood cell count abnormalFAERS: 20US FAERS
252AphagiaFAERS: 19US FAERS
253AtelectasisFAERS: 19US FAERS
254ChromaturiaFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
255DiplopiaFAERS: 19US FAERS
256Exposure via partnerFAERS: 19US FAERS
257Lichen PlanusFAERS: 19US FAERS
258Renal Cell CarcinomaFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
259nervous system disorderFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
260AgeusiaFAERS: 18US FAERS
261ArthropathyFAERS: 18
Canada Vigilance: 3
Canada Vigilance
US FAERS
262CholecystitisFAERS: 18US FAERS
263CyanosisFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
264Decreased immune responsivenessFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
265Diabetic RetinopathyFAERS: 18US FAERS
266DysarthriaFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
267Mental status changesFAERS: 18US FAERS
268MyositisFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
269PhotophobiaFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
270PleurisyFAERS: 18US FAERS
271Poor quality sleepFAERS: 18US FAERS
272VasculitisFAERS: 18
Canada Vigilance: 1
14576606CTD
Canada Vigilance
US FAERS
273Blood potassium increasedFAERS: 17US FAERS
274ColectomyFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
275Drug toxicityFAERS: 17US FAERS
276Gastrointestinal perforationFAERS: 17US FAERS
277HepatectomyFAERS: 17US FAERS
278HydronephrosisFAERS: 17US FAERS
279Joint injuryFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
280Lower respiratory tract infectionFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
281Malignant tumour excisionFAERS: 17US FAERS
282PericarditisFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
283Suicide attemptFAERS: 17US FAERS
284Visual disturbanceFAERS: 17US FAERS
285AngioedemaFAERS: 16US FAERS
286AphoniaFAERS: 16US FAERS
287Blood iron decreasedFAERS: 16
Canada Vigilance: 3
Canada Vigilance
US FAERS
288Blood sodium decreasedFAERS: 16US FAERS
289Cataract operationFAERS: 16US FAERS
290DermatitisFAERS: 16US FAERS
291Eye irritationFAERS: 16
Canada Vigilance: 3
Canada Vigilance
US FAERS
292Food PoisoningFAERS: 16US FAERS
293Full blood count abnormalFAERS: 16US FAERS
294HyperthyroidismFAERS: 16US FAERS
295Intestinal PerforationFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
296Lip swellingFAERS: 16US FAERS
297MenorrhagiaFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
298Myasthenia GravisFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
299Pulmonary congestionFAERS: 16US FAERS
300ToothacheFAERS: 16US FAERS
301VIIth nerve paralysisFAERS: 16US FAERS
302Wound ComplicationFAERS: 16US FAERS
303Bone marrow depressionFAERS: 15US FAERS
304CardiomegalyFAERS: 15US FAERS
305Cerebral disorderFAERS: 15US FAERS
306Flank PainFAERS: 15US FAERS
307FlushingFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
308GastroenteritisFAERS: 15US FAERS
309Gastrointestinal carcinomaFAERS: 15US FAERS
310HemiplegiaFAERS: 15US FAERS
311HydrocephalusFAERS: 15US FAERS
312InfarctionFAERS: 15US FAERS
313Limb discomfortFAERS: 15US FAERS
314Nephrotic SyndromeFAERS: 15US FAERS
315PurpuraFAERS: 1514576606CTD
US FAERS
316RetchingFAERS: 15US FAERS
317Skin reactionFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
318SneezingFAERS: 15US FAERS
319Acute respiratory failureFAERS: 14US FAERS
320AdenocarcinomaFAERS: 14US FAERS
321Autonomic neuropathyFAERS: 14US FAERS
322Blast cells presentFAERS: 14US FAERS
323Blood cholesterol increasedFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
324ChokingFAERS: 14US FAERS
325Eye InfectionFAERS: 14US FAERS
326Hepatitis CFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
327Lymphocyte count decreasedFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
328Multiple SclerosisFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
329Product physical issueFAERS: 14US FAERS
330Renal painFAERS: 14US FAERS
331ScabFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
332Spinal column stenosisFAERS: 14US FAERS
333Stevens-Johnson SyndromeFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
334Accidental overdoseFAERS: 13US FAERS
335Activities of daily living impairedFAERS: 13US FAERS
336AneurysmFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
337Blood blisterFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
338Bone marrow necrosisFAERS: 13US FAERS
339Cytolytic hepatitisFAERS: 13US FAERS
340Dental cariesFAERS: 13US FAERS
341Duodenal UlcerFAERS: 13US FAERS
342Fluid overloadFAERS: 13US FAERS
343Gait inabilityFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
344Gastric ulcerFAERS: 13US FAERS
345Gastrointestinal infectionFAERS: 13US FAERS
346HemiparesisFAERS: 13US FAERS
347HypokinesiaFAERS: 13US FAERS
348LaryngitisFAERS: 13US FAERS
349Musculoskeletal discomfortFAERS: 13US FAERS
350NeuralgiaFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
351OverdoseFAERS: 13US FAERS
352Temperature intoleranceFAERS: 13US FAERS
353Uterine CancerFAERS: 13US FAERS
354Wound InfectionFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
355Autoimmune hepatitisFAERS: 12US FAERS
356Bone density decreasedFAERS: 12US FAERS
357CalcinosisFAERS: 12US FAERS
358CholestasisFAERS: 12US FAERS
359Clostridium difficile colitisFAERS: 12US FAERS
360EncephalitisFAERS: 12US FAERS
361Eye inflammationFAERS: 12US FAERS
362Gene MutationFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
363HypersomniaFAERS: 12US FAERS
364Inappropriate schedule of drug administrationFAERS: 12US FAERS
365Irritable Bowel SyndromeFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
366LagophthalmosFAERS: 12US FAERS
367LaparotomyFAERS: 12US FAERS
368Large intestine perforationFAERS: 12US FAERS
369Lip and/or oral cavity cancerFAERS: 12US FAERS
370Lung AbscessFAERS: 12US FAERS
371MastectomyFAERS: 12US FAERS
372Medication ErrorFAERS: 12US FAERS
373Metastatic NeoplasmFAERS: 12US FAERS
374Occult blood positiveFAERS: 12US FAERS
375Oropharyngeal discomfortFAERS: 12US FAERS
376Philadelphia chromosome positiveFAERS: 12US FAERS
377PolyneuropathyFAERS: 12US FAERS
378PriapismFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
379Therapeutic response unexpectedFAERS: 12US FAERS
380Therapy responderFAERS: 12US FAERS
381ThrombophlebitisFAERS: 12US FAERS
382Thyroid NeoplasmFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
383Wrong technique in drug usage processFAERS: 12US FAERS
384AgitationFAERS: 11US FAERS
385Breast cancer recurrentFAERS: 11US FAERS
386Diffuse Large B-Cell LymphomaFAERS: 11US FAERS
387Disease complicationFAERS: 11US FAERS
388EpilepsyFAERS: 11US FAERS
389Erythema NodosumFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
390Gastrointestinal motility disorderFAERS: 11US FAERS
391Gastrointestinal toxicityFAERS: 11US FAERS
392HepatosplenomegalyFAERS: 11US FAERS
393Hip surgeryFAERS: 11US FAERS
394ImmunosuppressionFAERS: 11US FAERS
395Intervertebral Disc DegenerationFAERS: 11US FAERS
396Intestinal resectionFAERS: 11US FAERS
397Lymphocytic infiltrationFAERS: 11US FAERS
398MalabsorptionFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
399Maternal exposure timing unspecifiedFAERS: 11US FAERS
400Mental impairmentFAERS: 11US FAERS
401Metabolic acidosisFAERS: 11US FAERS
402NecrosisFAERS: 1119242505
19289603
CTD
US FAERS
403Optic NeuropathyFAERS: 11US FAERS
404Osteonecrosis of JawFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
405PancreaticoduodenectomyFAERS: 11US FAERS
406Procedural complicationFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
407RalesFAERS: 11US FAERS
408Rheumatoid ArthritisFAERS: 11US FAERS
409SarcomaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
410Therapy cessationFAERS: 11US FAERS
411Throat irritationFAERS: 11US FAERS
412Unevaluable eventFAERS: 11US FAERS
413Apparent deathFAERS: 10US FAERS
414Blood albumin decreasedFAERS: 10US FAERS
415Blood sodium increasedFAERS: 10US FAERS
416Bronchopulmonary AspergillosisFAERS: 10US FAERS
417Colonic StenosisFAERS: 10US FAERS
418Complications of transplant surgeryFAERS: 10US FAERS
419Creatinine renal clearance decreasedFAERS: 10US FAERS
420Erythema MultiformeFAERS: 10US FAERS
421Exfoliative rashFAERS: 10US FAERS
422Hepatic EncephalopathyFAERS: 10US FAERS
423IntubationFAERS: 10US FAERS
424Lymphocyte count increasedFAERS: 10US FAERS
425Muscle CrampFAERS: 1017040091
17405756
CTD
US FAERS
426ObesityFAERS: 10US FAERS
427Optic NeuritisFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
428PharyngitisFAERS: 10US FAERS
429Platelet count abnormalFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
430PolyserositisFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
431PsoriasisFAERS: 10US FAERS
432Renal ColicFAERS: 10US FAERS
433SclerodermaFAERS: 10US FAERS
434SplenectomyFAERS: 10US FAERS
435Splenic RuptureFAERS: 10US FAERS
436Squamous cell carcinoma of skinFAERS: 10US FAERS
437TenosynovitisFAERS: 10US FAERS
438Tooth InfectionFAERS: 10US FAERS
439effusionFAERS: 10US FAERS
440muscle injuryFAERS: 10US FAERS
441Acute Coronary SyndromeFAERS: 9US FAERS
442Anal FissureFAERS: 9US FAERS
443AnuriaFAERS: 9US FAERS
444Back disorderFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
445Bladder neoplasm surgeryFAERS: 9US FAERS
446Blood triglycerides increasedFAERS: 9US FAERS
447BronchopneumoniaFAERS: 9US FAERS
448Central nervous system lesionFAERS: 9US FAERS
449Clostridium difficile infectionFAERS: 9US FAERS
450Cord blood transplant therapyFAERS: 9US FAERS
451DemyelinationFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
452EcchymosisFAERS: 9US FAERS
453Escherichia infectionFAERS: 9US FAERS
454FibromyalgiaFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
455Histiocytosis haematophagicFAERS: 9US FAERS
456HyperkeratosisFAERS: 9US FAERS
457HyperplasiaFAERS: 9US FAERS
458Intermittent ClaudicationFAERS: 9US FAERS
459MyocarditisFAERS: 9US FAERS
460Pulmonary thrombosisFAERS: 9US FAERS
461RestlessnessFAERS: 9US FAERS
462Skin hypertrophyFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
463Skin neoplasm excisionFAERS: 9US FAERS
464TransplantFAERS: 9US FAERS
465Urinary IncontinenceFAERS: 9US FAERS
466Venous ThrombosisFAERS: 9US FAERS
467Abdominal AbscessFAERS: 8US FAERS
468Adverse eventFAERS: 8US FAERS
469ArteriosclerosisFAERS: 8US FAERS
470Atrioventricular BlockFAERS: 8US FAERS
471Bipolar DisorderFAERS: 8US FAERS
472Bladder NeoplasmFAERS: 8US FAERS
473Blood amylase increasedFAERS: 8US FAERS
474CardiotoxicityFAERS: 8
Canada Vigilance: 5
Canada Vigilance
US FAERS
475Carpal Tunnel SyndromeFAERS: 8US FAERS
476CholangitisFAERS: 8US FAERS
477Cold sweatFAERS: 8US FAERS
478CryingFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
479Deafness NeurosensoryFAERS: 8US FAERS
480DeliriumFAERS: 8US FAERS
481Diabetic NephropathyFAERS: 8US FAERS
482Drug ToleranceFAERS: 8US FAERS
483EructationFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
484Facial paralysisFAERS: 8US FAERS
485Gastrointestinal PainFAERS: 8US FAERS
486Gastrointestinal mucosal disorderFAERS: 8US FAERS
487Hypertensive crisisFAERS: 8US FAERS
488Impaired gastric emptyingFAERS: 8US FAERS
489InfertilityFAERS: 831278918CTD
US FAERS
490Intervertebral disc disorderFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
491Leukaemic infiltration brainFAERS: 8US FAERS
492Ligament ruptureFAERS: 8US FAERS
493Lip erosionFAERS: 8US FAERS
494Muscle strainFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
495Musculoskeletal chest painFAERS: 8US FAERS
496NephrectomyFAERS: 8US FAERS
497Ocular icterusFAERS: 8US FAERS
498Oral candidiasisFAERS: 8US FAERS
499Performance status decreasedFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
500Pharyngolaryngeal PainFAERS: 8US FAERS
501RegurgitationFAERS: 8US FAERS
502Restless Legs SyndromeFAERS: 8US FAERS
503SciaticaFAERS: 8US FAERS
504Skin toxicityFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
505Toxic Epidermal NecrolysisFAERS: 8US FAERS
506VitiligoFAERS: 8US FAERS
507Vitreous DetachmentFAERS: 8US FAERS
508Abdominal adhesionsFAERS: 7US FAERS
509AmaurosisFAERS: 7US FAERS
510Aortic AneurysmFAERS: 7US FAERS
511AsthenopiaFAERS: 7US FAERS
512Biopsy bone marrow abnormalFAERS: 7US FAERS
513Blood follicle stimulating hormone increasedFAERS: 7US FAERS
514BronchiolitisFAERS: 7US FAERS
515BronchospasmFAERS: 7US FAERS
516CandidiasisFAERS: 7US FAERS
517Cervix carcinomaFAERS: 7US FAERS
518Compression fractureFAERS: 7US FAERS
519Dermatofibrosarcoma ProtuberansFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
520Drug dispensing errorFAERS: 7US FAERS
521Drug level increasedFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
522DuodenitisFAERS: 7US FAERS
523DyscheziaFAERS: 7US FAERS
524DysgraphiaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
525Emotional disorderFAERS: 7US FAERS
526EndocarditisFAERS: 7US FAERS
527Extremity necrosisFAERS: 7US FAERS
528Gastrointestinal inflammationFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
529Granulocyte count decreasedFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
530Head discomfortFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
531Hypereosinophilic syndromeFAERS: 720169542
28347583
CTD
US FAERS
532HyperpyrexiaFAERS: 7US FAERS
533Hyperviscosity syndromeFAERS: 7US FAERS
534Inappropriate schedule of product administrationFAERS: 7US FAERS
535Increased tendency to bruiseFAERS: 7US FAERS
536Intracranial AneurysmFAERS: 7US FAERS
537Joint stiffnessFAERS: 7
Canada Vigilance: 3
Canada Vigilance
US FAERS
538Mastication disorderFAERS: 7US FAERS
539MeningitisFAERS: 7US FAERS
540MonoplegiaFAERS: 7US FAERS
541Mood swingsFAERS: 7US FAERS
542Muscle RigidityFAERS: 7US FAERS
543Nerve injuryFAERS: 7US FAERS
544Optic AtrophyFAERS: 7US FAERS
545OsteopeniaFAERS: 7US FAERS
546ParotitisFAERS: 7US FAERS
547Pathological fractureFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
548Pelvic massFAERS: 7US FAERS
549Pleuritic painFAERS: 7US FAERS
550PoisoningFAERS: 7US FAERS
551Polymerase Chain ReactionFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
552Postoperative ileusFAERS: 7US FAERS
553Protein total decreasedFAERS: 7US FAERS
554PyelonephritisFAERS: 7US FAERS
555Rectal StenosisFAERS: 7US FAERS
556Retinal Artery OcclusionFAERS: 7US FAERS
557Rotator cuff syndromeFAERS: 7US FAERS
558SchizophreniaFAERS: 7US FAERS
559Sexual DysfunctionFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
560Supraventricular tachycardiaFAERS: 7US FAERS
561Synovial CystFAERS: 7US FAERS
562TachyarrhythmiaFAERS: 7US FAERS
563Therapy changeFAERS: 7US FAERS
564Thermal burnFAERS: 7US FAERS
565Thoracic cavity drainageFAERS: 7US FAERS
566Throat cancerFAERS: 7US FAERS
567Tooth LossFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
568Unresponsive to stimuliFAERS: 7US FAERS
569UveitisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
570Viral upper respiratory tract infectionFAERS: 7US FAERS
571X-ray abnormalFAERS: 7US FAERS
572Accidental exposure to productFAERS: 6US FAERS
573AcidosisFAERS: 6US FAERS
574Allogenic bone marrow transplantation therapyFAERS: 6US FAERS
575Anaphylactic shockFAERS: 6US FAERS
576AtaxiaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
577Atrial FlutterFAERS: 6US FAERS
578Bilirubin conjugated increasedFAERS: 6US FAERS
579BlepharitisFAERS: 6US FAERS
580Bowel movement irregularityFAERS: 6
Canada Vigilance: 3
Canada Vigilance
US FAERS
581BradycardiaFAERS: 6US FAERS
582BradyphreniaFAERS: 6US FAERS
583Cardiac discomfortFAERS: 6US FAERS
584CheilitisFAERS: 6US FAERS
585Device related infectionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
586Diabetes mellitus inadequate controlFAERS: 6US FAERS
587Echocardiogram abnormalFAERS: 6US FAERS
588Ectopic PregnancyFAERS: 6US FAERS
589Electrocardiogram abnormalFAERS: 6US FAERS
590Epidermal necrosisFAERS: 6US FAERS
591Erectile dysfunctionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
592Expired product administeredFAERS: 6US FAERS
593Gastric infectionFAERS: 6US FAERS
594Gastrointestinal obstructionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
595Hepatitis AFAERS: 6US FAERS
596Hormone level abnormalFAERS: 6US FAERS
597Impaired driving abilityFAERS: 6US FAERS
598Impaired work abilityFAERS: 6US FAERS
599LymphadenitisFAERS: 6US FAERS
600MastocytosisFAERS: 6US FAERS
601Mechanical ventilationFAERS: 6US FAERS
602Medical device complicationFAERS: 6US FAERS
603Metastases to abdominal cavityFAERS: 6US FAERS
604MetrorrhagiaFAERS: 6US FAERS
605Monocyte count increasedFAERS: 6US FAERS
606Muscle SpasticityFAERS: 6US FAERS
607Muscle tightnessFAERS: 6US FAERS
608MyopathyFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
609Personality ChangeFAERS: 6US FAERS
610Pleural MesotheliomaFAERS: 6US FAERS
611Pneumocystis jiroveci pneumoniaFAERS: 6US FAERS
612PolyuriaFAERS: 6US FAERS
613Poor quality drug administeredFAERS: 6US FAERS
614PregnancyFAERS: 6US FAERS
615PresyncopeFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
616Pulmonary arterial hypertensionFAERS: 6US FAERS
617Pulmonary function test decreasedFAERS: 6US FAERS
618Purulent dischargeFAERS: 6US FAERS
619Renal tubular necrosisFAERS: 6US FAERS
620Skin ErosionFAERS: 6US FAERS
621Skin PapillomaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
622Status EpilepticusFAERS: 6US FAERS
623ThirstFAERS: 6US FAERS
624ThyroidectomyFAERS: 6US FAERS
625Tonic clonic movementsFAERS: 6US FAERS
626Trigeminal palsyFAERS: 6US FAERS
627Upper respiratory tract inflammationFAERS: 6US FAERS
628Urine output increasedFAERS: 6US FAERS
629Abdominal cavity drainageFAERS: 5US FAERS
630Abdominal wall cystFAERS: 5US FAERS
631Amyotrophic Lateral SclerosisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
632Anal FistulaFAERS: 5US FAERS
633Aphthous StomatitisFAERS: 5US FAERS
634Arterial thrombosisFAERS: 5US FAERS
635AsterixisFAERS: 5US FAERS
636AzoospermiaFAERS: 5US FAERS
637Basilar Artery StenosisFAERS: 5US FAERS
638BicytopeniaFAERS: 5US FAERS
639Biopsy liver abnormalFAERS: 5US FAERS
640Blood fibrinogen decreasedFAERS: 5US FAERS
641Blood phosphorus decreasedFAERS: 5US FAERS
642Blood thyroid stimulating hormone increasedFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
643Bone erosionFAERS: 5US FAERS
644Bone lesionFAERS: 5US FAERS
645Breech PresentationFAERS: 5US FAERS
646Bronchoscopy abnormalFAERS: 5US FAERS
647Calcification of muscleFAERS: 5US FAERS
648Cardiac FlutterFAERS: 5US FAERS
649Cardiac TamponadeFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
650Catheter placementFAERS: 5US FAERS
651Cerebellar HypoplasiaFAERS: 5US FAERS
652Cervical dysplasiaFAERS: 5US FAERS
653Cervical myelopathyFAERS: 5US FAERS
654Congenital hydronephrosisFAERS: 5US FAERS
655DiverticulumFAERS: 5US FAERS
656Drug DependenceFAERS: 5US FAERS
657Drug prescribing errorFAERS: 5US FAERS
658EnterocolitisFAERS: 5US FAERS
659EpisiotomyFAERS: 5US FAERS
660Escherichia sepsisFAERS: 5US FAERS
661ExcoriationFAERS: 5US FAERS
662ExophthalmosFAERS: 5US FAERS
663Facial PainFAERS: 5US FAERS
664FasciitisFAERS: 5US FAERS
665Feeling of body temperature changeFAERS: 5US FAERS
666GlomerulonephritisFAERS: 5
Canada Vigilance: 1
19242505CTD
Canada Vigilance
US FAERS
667Heat StrokeFAERS: 5US FAERS
668HyperchlorhydriaFAERS: 5US FAERS
669HyperleukocytosisFAERS: 5US FAERS
670HypogonadismFAERS: 5US FAERS
671Immune thrombocytopenic purpuraFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
672Increased upper airway secretionFAERS: 5US FAERS
673Joint fluid drainageFAERS: 5US FAERS
674Liver carcinoma rupturedFAERS: 5US FAERS
675LymphopeniaFAERS: 5US FAERS
676MacrocytosisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
677MastoiditisFAERS: 5US FAERS
678Maternal exposure before pregnancyFAERS: 5US FAERS
679MeningiomaFAERS: 5US FAERS
680Metastases to adrenalsFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
681Mononeuropathy MultiplexFAERS: 5US FAERS
682Muscle abscessFAERS: 5US FAERS
683Natural killer cell count increasedFAERS: 5US FAERS
684Neonatal respiratory failureFAERS: 5US FAERS
685NephritisFAERS: 5US FAERS
686Neurological decompensationFAERS: 5US FAERS
687OnychoclasisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
688Oral infectionFAERS: 5US FAERS
689Oral mucosal exfoliationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
690OsteolysisFAERS: 515867366CTD
US FAERS
691Pancreatic NeoplasmFAERS: 5US FAERS
692PanniculitisFAERS: 5US FAERS
693ParakeratosisFAERS: 5US FAERS
694ParaplegiaFAERS: 5US FAERS
695Pelvic PainFAERS: 5US FAERS
696Peritoneal lesionFAERS: 5US FAERS
697Portal HypertensionFAERS: 5US FAERS
698SarcoidosisFAERS: 5US FAERS
699Sinus TachycardiaFAERS: 5US FAERS
700Skin irritationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
701SluggishnessFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
702Subcutaneous AbscessFAERS: 5US FAERS
703Teeth brittleFAERS: 5US FAERS
704Tooth ExtractionFAERS: 5US FAERS
705Ultrasound Doppler abnormalFAERS: 5US FAERS
706Vaginal DischargeFAERS: 5US FAERS
707Vascular occlusionFAERS: 5US FAERS
708Vascular ruptureFAERS: 5US FAERS
709Vocal Cord ParalysisFAERS: 5US FAERS
710skin abrasionFAERS: 5US FAERS
711Abdominal tendernessFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
712AcanthosisFAERS: 4US FAERS
713Accidental deathFAERS: 4US FAERS
714Alanine aminotransferase abnormalFAERS: 4US FAERS
715Aldolase increasedFAERS: 4US FAERS
716Ammonia increasedFAERS: 4US FAERS
717Anal UlcerFAERS: 4US FAERS
718Anal abscessFAERS: 4US FAERS
719Anastomotic stenosisFAERS: 4US FAERS
720AngioplastyFAERS: 4US FAERS
721Angiotensin converting enzyme increasedFAERS: 4US FAERS
722Animal biteFAERS: 4US FAERS
723AnosmiaFAERS: 4US FAERS
724AspergillosisFAERS: 4US FAERS
725Atrial tachycardiaFAERS: 4US FAERS
726Benign Prostatic HyperplasiaFAERS: 4US FAERS
727Bladder discomfortFAERS: 4US FAERS
728Blast cell proliferationFAERS: 4US FAERS
729Blighted ovumFAERS: 4US FAERS
730Blood bilirubin unconjugated increasedFAERS: 4US FAERS
731Blood creatinine abnormalFAERS: 4US FAERS
732Blood creatinine decreasedFAERS: 4US FAERS
733Blood immunoglobulin A increasedFAERS: 4US FAERS
734Blood magnesium decreasedFAERS: 4US FAERS
735Body height below normalFAERS: 4US FAERS
736Bone formation decreasedFAERS: 4US FAERS
737Bone marrow myelogram abnormalFAERS: 4US FAERS
738Bone marrow reticulin fibrosisFAERS: 4US FAERS
739Bone marrow toxicityFAERS: 4US FAERS
740Brain DeathFAERS: 4US FAERS
741Brain natriuretic peptide increasedFAERS: 4US FAERS
742BronchiectasisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
743BursitisFAERS: 4US FAERS
744Cardiovascular insufficiencyFAERS: 4US FAERS
745Cartilage injuryFAERS: 4US FAERS
746Cerebral atrophyFAERS: 4US FAERS
747CholangiocarcinomaFAERS: 4US FAERS
748Colon adenomaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
749Cyst removalFAERS: 4US FAERS
750Diabetic KetoacidosisFAERS: 4US FAERS
751Drug effect incompleteFAERS: 4US FAERS
752Drug level below therapeuticFAERS: 4US FAERS
753DysenteryFAERS: 4US FAERS
754DyslexiaFAERS: 4US FAERS
755DysphasiaFAERS: 4US FAERS
756EmbolismFAERS: 4US FAERS
757Emotional distressFAERS: 4US FAERS
758EnteritisFAERS: 4US FAERS
759Eosinophilic FasciitisFAERS: 4US FAERS
760Epigastric discomfortFAERS: 4US FAERS
761ErysipelasFAERS: 4US FAERS
762Failure to ThriveFAERS: 4US FAERS
763FibrosarcomaFAERS: 4US FAERS
764FibrosisFAERS: 4US FAERS
765FolliculitisFAERS: 4US FAERS
766Gastric tube reconstructionFAERS: 4US FAERS
767Gastrointestinal cancer metastaticFAERS: 4US FAERS
768Gastrointestinal ulcerFAERS: 4US FAERS
769Gastrointestinal viral infectionFAERS: 4US FAERS
770Gestational DiabetesFAERS: 4US FAERS
771GliomaFAERS: 420198329
20512610
CTD
US FAERS
772GlossitisFAERS: 4US FAERS
773Graft versus host disease in liverFAERS: 4US FAERS
774Graft versus host disease in lungFAERS: 4US FAERS
775Guillain-Barre SyndromeFAERS: 4US FAERS
776Hepatic congestionFAERS: 4US FAERS
777Hypertensive cardiomyopathyFAERS: 4US FAERS
778Implant site infectionFAERS: 4US FAERS
779Implant site reactionFAERS: 4US FAERS
780Incorrect route of drug administrationFAERS: 4US FAERS
781Increased bronchial secretionFAERS: 4US FAERS
782Infectious peritonitisFAERS: 4US FAERS
783Intestinal cystFAERS: 4US FAERS
784Intestinal stomaFAERS: 4US FAERS
785Intra-abdominal pressure increasedFAERS: 4US FAERS
786Left Ventricular HypertrophyFAERS: 4US FAERS
787Left atrial dilatationFAERS: 4US FAERS
788Leucine aminopeptidase increasedFAERS: 4US FAERS
789Lipoma of breastFAERS: 4US FAERS
790Lymphoblast count increasedFAERS: 4US FAERS
791Mass excisionFAERS: 4US FAERS
792Meningeal disorderFAERS: 4US FAERS
793MeningorrhagiaFAERS: 4US FAERS
794Metastases to pelvisFAERS: 4US FAERS
795Metastases to stomachFAERS: 4US FAERS
796Mitral Valve StenosisFAERS: 4US FAERS
797Mouth swellingFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
798MyelocytosisFAERS: 4US FAERS
799Nasal discomfortFAERS: 4US FAERS
800Nephrogenic Systemic FibrosisFAERS: 4US FAERS
801NeuropathyFAERS: 4US FAERS
802Neutropenic colitisFAERS: 4US FAERS
803OliguriaFAERS: 4US FAERS
804Otitis MediaFAERS: 4US FAERS
805Ovarian enlargementFAERS: 4US FAERS
806OverweightFAERS: 4US FAERS
807Pain of skinFAERS: 4US FAERS
808ParesisFAERS: 4US FAERS
809Perforated ulcerFAERS: 4US FAERS
810Pharmaceutical product complaintFAERS: 4US FAERS
811PlasmacytosisFAERS: 4US FAERS
812Poor peripheral circulationFAERS: 4US FAERS
813Post procedural bile leakFAERS: 4US FAERS
814Post procedural infectionFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
815Prescribed underdoseFAERS: 4US FAERS
816ProctitisFAERS: 4US FAERS
817Product packaging issueFAERS: 4US FAERS
818Product storage errorFAERS: 4US FAERS
819Product use complaintFAERS: 4US FAERS
820Pulmonary granulomaFAERS: 4US FAERS
821Pulmonary toxicityFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
822Quality of life decreasedFAERS: 4US FAERS
823Rectal polypFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
824Refractory cytopenia with multilineage dysplasiaFAERS: 4US FAERS
825Remission not achievedFAERS: 4US FAERS
826Renal cancer metastaticFAERS: 4US FAERS
827Renal massFAERS: 4US FAERS
828Retinal Vascular DisorderFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
829RhinitisFAERS: 4US FAERS
830Sicca SyndromeFAERS: 4US FAERS
831Skeletal injuryFAERS: 4US FAERS
832Skin necrosisFAERS: 4US FAERS
833Small intestine carcinomaFAERS: 4US FAERS
834Spinal fusion surgeryFAERS: 4US FAERS
835SpondylitisFAERS: 4US FAERS
836SpondylolisthesisFAERS: 4US FAERS
837Subcutaneous noduleFAERS: 4US FAERS
838Temporal ArteritisFAERS: 4US FAERS
839Tensilon test abnormalFAERS: 4US FAERS
840Therapeutic procedureFAERS: 4US FAERS
841Traumatic Brain InjuryFAERS: 4US FAERS
842Troponin increasedFAERS: 4US FAERS
843UnderweightFAERS: 4US FAERS
844Urinary tract obstructionFAERS: 4US FAERS
845Urine calcium increasedFAERS: 4US FAERS
846Vascular calcificationFAERS: 4US FAERS
847Ventricular DysfunctionFAERS: 4US FAERS
848Wound infection pseudomonasFAERS: 4US FAERS
849XerosisFAERS: 4US FAERS
850neurofibromaFAERS: 4US FAERS
851Abdominal sepsisFAERS: 3US FAERS
852Actinic keratosisFAERS: 3US FAERS
853Acute sinusitisFAERS: 3US FAERS
854Adams-Stokes SyndromeFAERS: 3US FAERS
855AkinesiaFAERS: 3US FAERS
856AlveolitisFAERS: 3US FAERS
857AmputationFAERS: 3US FAERS
858Amylase increasedFAERS: 3US FAERS
859AnencephalyFAERS: 3US FAERS
860ApathyFAERS: 3US FAERS
861Arteriosclerosis ObliteransFAERS: 3US FAERS
862Arthropod biteFAERS: 3US FAERS
863Artificial crown procedureFAERS: 3US FAERS
864Aspartate aminotransferase decreasedFAERS: 3US FAERS
865Bacterial sepsisFAERS: 3US FAERS
866BedriddenFAERS: 3US FAERS
867Bipolar I disorderFAERS: 3US FAERS
868Blood bilirubin abnormalFAERS: 3US FAERS
869Blood chloride increasedFAERS: 3US FAERS
870Blood creatine increasedFAERS: 3US FAERS
871Blood glucose abnormalFAERS: 3US FAERS
872Blood immunoglobulin G increasedFAERS: 3US FAERS
873Blood mercury abnormalFAERS: 3US FAERS
874Blood phosphorus increasedFAERS: 3US FAERS
875Bone infarctionFAERS: 3US FAERS
876Breast CystFAERS: 3US FAERS
877Bronchoalveolar lavage abnormalFAERS: 3US FAERS
878Cancer PainFAERS: 3US FAERS
879Candida sepsisFAERS: 3US FAERS
880Capillary FragilityFAERS: 3US FAERS
881Capillary Leak SyndromeFAERS: 3US FAERS
882Cardiac DeathFAERS: 3US FAERS
883Cardiac enzymes increasedFAERS: 3US FAERS
884Carnitine decreasedFAERS: 3US FAERS
885Cell marker increasedFAERS: 3US FAERS
886Central Nervous System InfectionFAERS: 3US FAERS
887ChordomaFAERS: 3US FAERS
888Chronic respiratory failureFAERS: 3US FAERS
889Citrobacter infectionFAERS: 3US FAERS
890Clonal EvolutionFAERS: 3US FAERS
891Colonic fistulaFAERS: 3US FAERS
892Coma scale abnormalFAERS: 3US FAERS
893Complications of bone marrow transplantFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
894Complications of maternal exposure to therapeutic drugsFAERS: 3US FAERS
895Coombs test positiveFAERS: 3US FAERS
896Cytomegalovirus antibody positiveFAERS: 3US FAERS
897Dacryostenosis acquiredFAERS: 3US FAERS
898DermatomyositisFAERS: 3US FAERS
899Device occlusionFAERS: 3US FAERS
900Diabetic FootFAERS: 3US FAERS
901Diaphragmatic HerniaFAERS: 3US FAERS
902Diffuse alveolar damageFAERS: 3US FAERS
903DiplegiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
904Drug exposure before pregnancyFAERS: 3US FAERS
905Drug withdrawal syndromeFAERS: 3US FAERS
906Duodenal perforationFAERS: 3US FAERS
907Ear congestionFAERS: 3US FAERS
908Early satietyFAERS: 3US FAERS
909EcthymaFAERS: 3US FAERS
910Electrocardiogram repolarisation abnormalityFAERS: 3US FAERS
911Electroencephalogram abnormalFAERS: 3US FAERS
912Enamel anomalyFAERS: 3US FAERS
913EndometriosisFAERS: 3US FAERS
914Endoscopic Retrograde CholangiopancreatographyFAERS: 3US FAERS
915Enterococcal infectionFAERS: 3US FAERS
916Enterocolitis bacterialFAERS: 3US FAERS
917Eosinophilic PneumoniaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
918Euphoric moodFAERS: 3US FAERS
919Facial ParesisFAERS: 3US FAERS
920Fibrin D dimer increasedFAERS: 3US FAERS
921FibromatosisFAERS: 3US FAERS
922Food cravingFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
923Gastrointestinal stromal cancerFAERS: 3US FAERS
924Graft versus host disease in skinFAERS: 3US FAERS
925Heart sounds abnormalFAERS: 3US FAERS
926Hepatic InfectionFAERS: 3US FAERS
927Hepatic cancer stage IVFAERS: 3US FAERS
928Hepatitis C virus test positiveFAERS: 3US FAERS
929Hepatitis EFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
930HydrothoraxFAERS: 3US FAERS
931HypercapniaFAERS: 3US FAERS
932Hyperkeratosis palmaris and plantarisFAERS: 3US FAERS
933Hypertensive heart diseaseFAERS: 3US FAERS
934HypoventilationFAERS: 3US FAERS
935HysterectomyFAERS: 3US FAERS
936Incision site painFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
937IncontinenceFAERS: 3US FAERS
938Infectious colitisFAERS: 3US FAERS
939Insulin ResistanceFAERS: 3US FAERS
940Insurance issueFAERS: 3US FAERS
941Interleukin level increasedFAERS: 3US FAERS
942Intestinal infarctionFAERS: 3US FAERS
943IntussusceptionFAERS: 3US FAERS
944Iron deficiencyFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
945Jejunal StenosisFAERS: 3US FAERS
946JejunectomyFAERS: 3US FAERS
947Joint Range of Motion DecreasedFAERS: 3US FAERS
948Klebsiella test positiveFAERS: 3US FAERS
949LabyrinthitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
950LacerationFAERS: 3US FAERS
951Left ventricular end-diastolic pressure increasedFAERS: 3US FAERS
952LichenificationFAERS: 3US FAERS
953Localised intraabdominal fluid collectionFAERS: 3US FAERS
954Loose toothFAERS: 3US FAERS
955Low birth weight babyFAERS: 3US FAERS
956LymphocytosisFAERS: 3US FAERS
957Mantle cell lymphomaFAERS: 3US FAERS
958Megakaryocytes increasedFAERS: 3US FAERS
959MesotheliomaFAERS: 321645609
21787763
CTD
US FAERS
960Monocyte count decreasedFAERS: 3US FAERS
961MultimorbidityFAERS: 3US FAERS
962Muscle FatigueFAERS: 3US FAERS
963Muscle enzyme increasedFAERS: 3US FAERS
964Myelocyte count increasedFAERS: 3US FAERS
965Myoglobin blood increasedFAERS: 3US FAERS
966Nephritis allergicFAERS: 3US FAERS
967Neutrophil count abnormalFAERS: 3US FAERS
968NystagmusFAERS: 3US FAERS
969OnycholysisFAERS: 3US FAERS
970Oral mucosal eruptionFAERS: 3US FAERS
971OsteitisFAERS: 3US FAERS
972OsteochondrosisFAERS: 3US FAERS
973Otitis ExternaFAERS: 3US FAERS
974PapuleFAERS: 3US FAERS
975Paranasal sinus discomfortFAERS: 3US FAERS
976ParanoiaFAERS: 3US FAERS
977ParapsoriasisFAERS: 3US FAERS
978Paternal exposure during pregnancyFAERS: 3US FAERS
979PeriarthritisFAERS: 3US FAERS
980PeriodontitisFAERS: 3US FAERS
981Periorbital swellingFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
982PhlebitisFAERS: 3US FAERS
983Placental InsufficiencyFAERS: 3US FAERS
984PlasmacytomaFAERS: 3US FAERS
985PleuropericarditisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
986Pneumatosis Cystoides IntestinalisFAERS: 3US FAERS
987Pneumatosis intestinalisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
988PolydipsiaFAERS: 3US FAERS
989Polyglandular disorderFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
990Poor weight gain neonatalFAERS: 3US FAERS
991Porphyria non-acuteFAERS: 3US FAERS
992Pre-EclampsiaFAERS: 3US FAERS
993Pregnancy of partnerFAERS: 3US FAERS
994PresbyopiaFAERS: 3US FAERS
995Product prescribing errorFAERS: 3US FAERS
996Protein-losing gastroenteropathyFAERS: 3US FAERS
997PrurigoFAERS: 3US FAERS
998Pulmonary sepsisFAERS: 3US FAERS
999Pyoderma GangrenosumFAERS: 3US FAERS
1000QuadriparesisFAERS: 3US FAERS
1001Rectosigmoid cancerFAERS: 3US FAERS
1002Renal tubular disorderFAERS: 3US FAERS
1003Reticulocyte count increasedFAERS: 3US FAERS
1004Right ventricular failureFAERS: 3US FAERS
1005Ruptured cerebral aneurysmFAERS: 3US FAERS
1006Scan bone marrow abnormalFAERS: 3US FAERS
1007ScotomaFAERS: 3US FAERS
1008Secretion dischargeFAERS: 3US FAERS
1009Semen volume decreasedFAERS: 3US FAERS
1010Sense of oppressionFAERS: 3US FAERS
1011Shoulder deformityFAERS: 3US FAERS
1012SigmoiditisFAERS: 3US FAERS
1013Skin noduleFAERS: 3US FAERS
1014Skin tightnessFAERS: 3US FAERS
1015Sperm concentration decreasedFAERS: 3US FAERS
1016Spleen palpableFAERS: 3US FAERS
1017StillbirthFAERS: 3US FAERS
1018Stomach dilation procedureFAERS: 3US FAERS
1019StridorFAERS: 3US FAERS
1020SunburnFAERS: 3
Canada Vigilance: 4
Canada Vigilance
US FAERS
1021SynovitisFAERS: 3US FAERS
1022Tinea PedisFAERS: 3US FAERS
1023Unexpected therapeutic drug effectFAERS: 3US FAERS
1024Urinary tract infection pseudomonalFAERS: 3US FAERS
1025Uterine ProlapseFAERS: 3US FAERS
1026Ventricular FibrillationFAERS: 3US FAERS
1027Ventricular arrhythmiaFAERS: 3US FAERS
1028Vitreous floatersFAERS: 3US FAERS
1029Vulvovaginal erythemaFAERS: 3US FAERS
1030Vulvovaginal rashFAERS: 3US FAERS
1031colonoscopyFAERS: 3US FAERS
1032Abdominal InfectionFAERS: 2US FAERS
1033Abdominal rigidityFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1034Accidental drug intake by childFAERS: 2US FAERS
1035Acoustic NeuromaFAERS: 2US FAERS
1036Acute graft versus host disease in intestineFAERS: 2US FAERS
1037Acute graft versus host disease in skinFAERS: 2US FAERS
1038Adenoid Cystic CarcinomaFAERS: 2US FAERS
1039Adnexa uteri cystFAERS: 2US FAERS
1040Adnexa uteri massFAERS: 2US FAERS
1041Air EmbolismFAERS: 2US FAERS
1042Alanine aminotransferase decreasedFAERS: 2US FAERS
1043AlbinismFAERS: 2US FAERS
1044Alcohol poisoningFAERS: 2US FAERS
1045Allergic sinusitisFAERS: 2US FAERS
1046Alpha hydroxybutyrate dehydrogenase increasedFAERS: 2US FAERS
1047Amaurosis FugaxFAERS: 2US FAERS
1048Anal infectionFAERS: 2US FAERS
1049Anal inflammationFAERS: 2US FAERS
1050Anaphylactoid ReactionFAERS: 2US FAERS
1051Anastomotic complicationFAERS: 2US FAERS
1052AngerFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1053Angle Closure GlaucomaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1054Ankylosing spondylitisFAERS: 2US FAERS
1055Anorectal discomfortFAERS: 2US FAERS
1056Anorectal operationFAERS: 2US FAERS
1057Anorexia NervosaFAERS: 2US FAERS
1058Antinuclear antibody increasedFAERS: 2US FAERS
1059Aortic Valve StenosisFAERS: 2US FAERS
1060Aortic surgeryFAERS: 2US FAERS
1061Aortic valve sclerosisFAERS: 2US FAERS
1062Arteriogram coronary abnormalFAERS: 2US FAERS
1063ArteritisFAERS: 2US FAERS
1064Autoimmune thyroiditisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1065Autonomic nervous system imbalanceFAERS: 2US FAERS
1066B-lymphocyte count increasedFAERS: 2US FAERS
1067Bacterial test positiveFAERS: 2US FAERS
1068Benign NeoplasmFAERS: 2US FAERS
1069Benign neoplasm of thyroid glandFAERS: 2US FAERS
1070Biliary ColicFAERS: 2US FAERS
1071Biliary FistulaFAERS: 2US FAERS
1072Biliary dilatationFAERS: 2US FAERS
1073Biliary tract infectionFAERS: 2US FAERS
1074Biopsy ear abnormalFAERS: 2US FAERS
1075Biopsy skin abnormalFAERS: 2US FAERS
1076Bladder cancer recurrentFAERS: 2US FAERS
1077Bladder stenosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1078BlepharospasmFAERS: 2US FAERS
1079Blood antidiuretic hormone increasedFAERS: 2US FAERS
1080Blood chromogranin A increasedFAERS: 2US FAERS
1081Blood glucagon increasedFAERS: 2US FAERS
1082Blood immunoglobulin G decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1083Blood immunoglobulin M increasedFAERS: 2US FAERS
1084Blood iron increasedFAERS: 2US FAERS
1085Blood parathyroid hormone increasedFAERS: 2US FAERS
1086Blood pressure fluctuationFAERS: 2US FAERS
1087Blood pressure immeasurableFAERS: 2US FAERS
1088Blood pressure inadequately controlledFAERS: 2US FAERS
1089Blood product transfusion dependentFAERS: 2US FAERS
1090Blood thyroid stimulating hormone decreasedFAERS: 2US FAERS
1091Blood urea abnormalFAERS: 2US FAERS
1092Blood viscosity decreasedFAERS: 2US FAERS
1093Bone TuberculosisFAERS: 2US FAERS
1094Bone atrophyFAERS: 2US FAERS
1095Bone fissureFAERS: 2US FAERS
1096Brain HypoxiaFAERS: 2US FAERS
1097Bronchial ObstructionFAERS: 2US FAERS
1098Bronchial polypFAERS: 2US FAERS
1099Bronchopulmonary diseaseFAERS: 2US FAERS
1100C-reactive protein abnormalFAERS: 2US FAERS
1101C-telopeptideFAERS: 2US FAERS
1102Candida pneumoniaFAERS: 2US FAERS
1103Carbon dioxide decreasedFAERS: 2US FAERS
1104Carbon dioxide increasedFAERS: 2US FAERS
1105Cardiac dysfunctionFAERS: 2US FAERS
1106Cardiac stress test abnormalFAERS: 2US FAERS
1107Carotid artery aneurysmFAERS: 2US FAERS
1108Carotid artery occlusionFAERS: 2US FAERS
1109Catheter site infectionFAERS: 2US FAERS
1110Cerebellar infarctionFAERS: 2US FAERS
1111Cerebral Amyloid AngiopathyFAERS: 2US FAERS
1112Cerebral artery occlusionFAERS: 2US FAERS
1113Cerebral cystFAERS: 2US FAERS
1114Cerebral ventricle dilatationFAERS: 2US FAERS
1115Cervix carcinoma recurrentFAERS: 2US FAERS
1116Chemotherapeutic drug level increasedFAERS: 2US FAERS
1117Choking sensationFAERS: 2US FAERS
1118Cholecystitis infectiveFAERS: 2US FAERS
1119ChromatopsiaFAERS: 2US FAERS
1120Chronic graft versus host disease in liverFAERS: 2US FAERS
1121Chronic left ventricular failureFAERS: 2US FAERS
1122Clostridium colitisFAERS: 2US FAERS
1123Colon cancer recurrentFAERS: 2US FAERS
1124Colonoscopy normalFAERS: 2US FAERS
1125Colorectal cancer stage IFAERS: 2US FAERS
1126Complication associated with deviceFAERS: 2US FAERS
1127Congenital HydrocephalusFAERS: 2US FAERS
1128Congenital inguinal herniaFAERS: 2US FAERS
1129Conjunctival pallorFAERS: 2US FAERS
1130Corneal UlcerFAERS: 2US FAERS
1131Corneal erosionFAERS: 2US FAERS
1132Coronary artery insufficiencyFAERS: 2US FAERS
1133CraniotomyFAERS: 2US FAERS
1134Cytomegalovirus test positiveFAERS: 2US FAERS
1135Cytoreductive SurgeryFAERS: 2US FAERS
1136Dark circles under eyesFAERS: 2US FAERS
1137Depression suicidalFAERS: 2US FAERS
1138Device FailureFAERS: 2US FAERS
1139Device breakageFAERS: 2US FAERS
1140Diabetes InsipidusFAERS: 2US FAERS
1141Diabetic ulcerFAERS: 2US FAERS
1142Double Outlet Right VentricleFAERS: 2US FAERS
1143Douglas' pouch massFAERS: 2US FAERS
1144Duodenal ObstructionFAERS: 2US FAERS
1145Duodenal atresiaFAERS: 2US FAERS
1146DysplasiaFAERS: 2US FAERS
1147Dyspnoea exacerbatedFAERS: 2US FAERS
1148Ear discomfortFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1149Echography abnormalFAERS: 2US FAERS
1150EctropionFAERS: 2US FAERS
1151Electrocardiogram ST segment abnormalFAERS: 2US FAERS
1152ElephantiasisFAERS: 2US FAERS
1153Embolic strokeFAERS: 2US FAERS
1154EmpyemaFAERS: 2US FAERS
1155Engraft failureFAERS: 2US FAERS
1156EpididymitisFAERS: 2US FAERS
1157Epstein-Barr virus antibody positiveFAERS: 2US FAERS
1158Erection increasedFAERS: 2US FAERS
1159Erythroblast count increasedFAERS: 2US FAERS
1160ErythromelalgiaFAERS: 2US FAERS
1161ErythropeniaFAERS: 2US FAERS
1162Excessive cerumen productionFAERS: 2US FAERS
1163Exposure to toxic agentFAERS: 2US FAERS
1164Exposure via breast milkFAERS: 2US FAERS
1165Extra dose administeredFAERS: 2US FAERS
1166Extrinsic vascular compressionFAERS: 2US FAERS
1167Eye RednessFAERS: 2US FAERS
1168Eye laser surgeryFAERS: 2US FAERS
1169Factor VII DeficiencyFAERS: 2US FAERS
1170Febrile bone marrow aplasiaFAERS: 2US FAERS
1171Fistula dischargeFAERS: 2US FAERS
1172Fistula repairFAERS: 2US FAERS
1173Foreign body traumaFAERS: 2US FAERS
1174FormicationFAERS: 2US FAERS
1175Frustration tolerance decreasedFAERS: 2US FAERS
1176Gallbladder painFAERS: 2US FAERS
1177GammopathyFAERS: 2US FAERS
1178Gastric BypassFAERS: 2US FAERS
1179Gastric DilatationFAERS: 2US FAERS
1180Gastric adenomaFAERS: 2US FAERS
1181Gastrointestinal angiodysplasiaFAERS: 2US FAERS
1182Gastrointestinal bacterial infectionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1183Gastrointestinal procedural complicationFAERS: 2US FAERS
1184Gastrointestinal sounds abnormalFAERS: 2US FAERS
1185Gastrointestinal stenosisFAERS: 2US FAERS
1186Gastrointestinal telangiectasiaFAERS: 2US FAERS
1187Gastrointestinal wall thickeningFAERS: 2US FAERS
1188GastrostomyFAERS: 2US FAERS
1189General symptomFAERS: 2US FAERS
1190Glaucoma surgeryFAERS: 2US FAERS
1191GlioblastomaFAERS: 2US FAERS
1192GliosisFAERS: 2US FAERS
1193Granulocytes maturation arrestFAERS: 2US FAERS
1194GranulomaFAERS: 2US FAERS
1195Grip strength decreasedFAERS: 2US FAERS
1196Hallucinations, mixedFAERS: 2US FAERS
1197Haptoglobin DecreasedFAERS: 2US FAERS
1198Hepaplastin increasedFAERS: 2US FAERS
1199Hepatitis B antibody positiveFAERS: 2US FAERS
1200Hepatitis C positiveFAERS: 2US FAERS
1201Hernial eventrationFAERS: 2US FAERS
1202HidradenitisFAERS: 2US FAERS
1203High frequency ablationFAERS: 2US FAERS
1204HordeolumFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1205Hydrocele operationFAERS: 2US FAERS
1206Hypertrophic CardiomyopathyFAERS: 2US FAERS
1207HypogeusiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1208HypoperfusionFAERS: 2US FAERS
1209HypospadiasFAERS: 2US FAERS
1210Hypothalamo-pituitary disorderFAERS: 2US FAERS
1211Iatrogenic injuryFAERS: 2US FAERS
1212Idiopathic Pulmonary FibrosisFAERS: 2US FAERS
1213Inability to afford medicationFAERS: 2US FAERS
1214Incision site abscessFAERS: 2US FAERS
1215Incision site infectionFAERS: 2US FAERS
1216Incorrect drug administration durationFAERS: 2US FAERS
1217Incorrect product storageFAERS: 2US FAERS
1218IndurationFAERS: 2US FAERS
1219Infected insect biteFAERS: 2US FAERS
1220Inflammatory marker increasedFAERS: 2US FAERS
1221Intracranial HypotensionFAERS: 2US FAERS
1222Invasive Ductal Breast CarcinomaFAERS: 2US FAERS
1223IridocyclitisFAERS: 2US FAERS
1224IritisFAERS: 2US FAERS
1225Iron OverloadFAERS: 2US FAERS
1226Joint abscessFAERS: 2US FAERS
1227Joint adhesionFAERS: 2US FAERS
1228KeratomileusisFAERS: 2US FAERS
1229Kidney congestionFAERS: 2US FAERS
1230Laryngeal discomfortFAERS: 2US FAERS
1231LaryngospasmFAERS: 2US FAERS
1232LentigoFAERS: 2US FAERS
1233LeukodermaFAERS: 2US FAERS
1234LeukoencephalopathyFAERS: 2US FAERS
1235Ligament injuryFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1236Lung consolidationFAERS: 2US FAERS
1237Lung neoplasm surgeryFAERS: 2US FAERS
1238Lymph Node TuberculosisFAERS: 2US FAERS
1239Maternal death during childbirthFAERS: 2US FAERS
1240Measles antibody positiveFAERS: 2US FAERS
1241MeaslesFAERS: 2US FAERS
1242Melanoma recurrentFAERS: 2US FAERS
1243Melanosis coliFAERS: 2US FAERS
1244Mental FatigueFAERS: 2US FAERS
1245Mesenteric PanniculitisFAERS: 2US FAERS
1246Metastases to abdominal wallFAERS: 2US FAERS
1247Middle insomniaFAERS: 2US FAERS
1248Migraine with AuraFAERS: 2US FAERS
1249Mole excisionFAERS: 2US FAERS
1250MonocytopeniaFAERS: 2US FAERS
1251Mucosal exfoliationFAERS: 2US FAERS
1252Mucosal pigmentationFAERS: 2US FAERS
1253Multiple sclerosis relapseFAERS: 2US FAERS
1254MutismFAERS: 2US FAERS
1255Myeloblast percentage increasedFAERS: 2US FAERS
1256Myelocyte count decreasedFAERS: 2US FAERS
1257Myeloid MetaplasiaFAERS: 2US FAERS
1258Myeloid maturation arrestFAERS: 2US FAERS
1259MyoglobinuriaFAERS: 2US FAERS
1260MyotoniaFAERS: 2US FAERS
1261Nasal PolypsFAERS: 2US FAERS
1262Non-cardiac chest painFAERS: 2US FAERS
1263Nutritional condition abnormalFAERS: 2US FAERS
1264Obesity surgeryFAERS: 2US FAERS
1265ObstructionFAERS: 2US FAERS
1266Ocular vascular disorderFAERS: 2US FAERS
1267OligohydramniosFAERS: 2US FAERS
1268Open woundFAERS: 2US FAERS
1269OphthalmoplegiaFAERS: 2US FAERS
1270Optic nerve infarctionFAERS: 2US FAERS
1271Oral fungal infectionFAERS: 2US FAERS
1272Oropharyngeal blisteringFAERS: 2US FAERS
1273Osteomyelitis fungalFAERS: 2US FAERS
1274Oxygen saturation increasedFAERS: 2US FAERS
1275PO2 decreasedFAERS: 2US FAERS
1276Pancreatic FistulaFAERS: 2US FAERS
1277Pancreatic InsufficiencyFAERS: 2US FAERS
1278Pancreatic enlargementFAERS: 2US FAERS
1279Panic DisorderFAERS: 2US FAERS
1280ParacentesisFAERS: 2US FAERS
1281Paraneoplastic dermatomyositisFAERS: 2US FAERS
1282Pelvic fluid collectionFAERS: 2US FAERS
1283Penis carcinomaFAERS: 2US FAERS
1284Peptic Ulcer PerforationFAERS: 2US FAERS
1285Peripheral embolismFAERS: 2US FAERS
1286Peripheral paralysisFAERS: 2US FAERS
1287Peritonsillar AbscessFAERS: 2US FAERS
1288PertussisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1289Physical deconditioningFAERS: 2US FAERS
1290Pityriasis RoseaFAERS: 2US FAERS
1291Platelet TransfusionFAERS: 2US FAERS
1292PolyarthritisFAERS: 2US FAERS
1293Polymerase chain reaction positiveFAERS: 2US FAERS
1294Polymyalgia RheumaticaFAERS: 2US FAERS
1295PoriomaniaFAERS: 2US FAERS
1296Post procedural sepsisFAERS: 2US FAERS
1297Postoperative infectionFAERS: 2US FAERS
1298Precancerous skin lesionFAERS: 2US FAERS
1299Prescribed overdoseFAERS: 2US FAERS
1300Primary sequestrumFAERS: 2US FAERS
1301Product coating issueFAERS: 2US FAERS
1302Product dispensing errorFAERS: 2US FAERS
1303Product dose omissionFAERS: 2US FAERS
1304Product packaging quantity issueFAERS: 2US FAERS
1305Promyelocyte count increasedFAERS: 2US FAERS
1306ProstatectomyFAERS: 2US FAERS
1307Prostatic AdenomaFAERS: 2US FAERS
1308Protein urine presentFAERS: 2US FAERS
1309Prothrombin level decreasedFAERS: 2US FAERS
1310Pseudomyxoma PeritoneiFAERS: 2US FAERS
1311PseudoporphyriaFAERS: 2US FAERS
1312Psoas AbscessFAERS: 2US FAERS
1313Psychiatric symptomFAERS: 2US FAERS
1314Pulmonary EosinophiliaFAERS: 2US FAERS
1315Pulmonary arterial pressure increasedFAERS: 2US FAERS
1316Radiation associated painFAERS: 2US FAERS
1317Rectal abscessFAERS: 2US FAERS
1318Renal OsteodystrophyFAERS: 2US FAERS
1319Renal abscessFAERS: 2US FAERS
1320Respiratory tract infection viralFAERS: 2US FAERS
1321Respiratory tract inflammationFAERS: 2US FAERS
1322Retinal DegenerationFAERS: 2US FAERS
1323Retinal Vein OcclusionFAERS: 2US FAERS
1324Retinal exudatesFAERS: 2US FAERS
1325Retroperitoneal fibrosisFAERS: 2US FAERS
1326Retroperitoneal massFAERS: 2US FAERS
1327Rheumatic disorderFAERS: 2US FAERS
1328Right atrial dilatationFAERS: 2US FAERS
1329Rubella in pregnancyFAERS: 2US FAERS
1330Salivary gland adenomaFAERS: 2US FAERS
1331SarcomatosisFAERS: 2US FAERS
1332ScreamingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1333SeminomaFAERS: 2US FAERS
1334Septal panniculitisFAERS: 2US FAERS
1335SerositisFAERS: 2US FAERS
1336SilicosisFAERS: 2US FAERS
1337Single functional kidneyFAERS: 2US FAERS
1338Sinus headacheFAERS: 2US FAERS
1339Sjogren's SyndromeFAERS: 2US FAERS
1340Skin lacerationFAERS: 2US FAERS
1341Sperm count decreasedFAERS: 2US FAERS
1342Spermatozoa morphology abnormalFAERS: 2US FAERS
1343Splenic neoplasm malignancy unspecifiedFAERS: 2US FAERS
1344SplenitisFAERS: 2US FAERS
1345SplenosisFAERS: 2US FAERS
1346StenosisFAERS: 2US FAERS
1347StuporFAERS: 2US FAERS
1348Subacute endocarditisFAERS: 2US FAERS
1349Sudden Cardiac DeathFAERS: 2US FAERS
1350Surfactant protein increasedFAERS: 2US FAERS
1351Suture insertionFAERS: 2US FAERS
1352SyndactylyFAERS: 2US FAERS
1353Systemic mycosisFAERS: 2US FAERS
1354TensionFAERS: 2US FAERS
1355TetanusFAERS: 2US FAERS
1356Thalamic infarctionFAERS: 2US FAERS
1357Thoracic vertebral fractureFAERS: 2US FAERS
1358Thyroid cancer metastaticFAERS: 2US FAERS
1359Thyroid hormones decreasedFAERS: 2US FAERS
1360TonsillitisFAERS: 2US FAERS
1361ToxoplasmosisFAERS: 2US FAERS
1362Tracheal StenosisFAERS: 2US FAERS
1363Transplantation complicationFAERS: 2US FAERS
1364TrismusFAERS: 2US FAERS
1365Troponin I increasedFAERS: 2US FAERS
1366Vascular fragilityFAERS: 2US FAERS
1367Venous thrombosis limbFAERS: 2US FAERS
1368Venous valve rupturedFAERS: 2US FAERS
1369Ventricular hypertrophyFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1370Ventricular hypokinesiaFAERS: 2US FAERS
1371Vertebrobasilar InsufficiencyFAERS: 2US FAERS
1372Vital functions abnormalFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1373VitrectomyFAERS: 2US FAERS
1374Vitreous opacitiesFAERS: 2US FAERS
1375Vocal cord cystFAERS: 2US FAERS
1376fibromaFAERS: 2US FAERS
1377keratoacanthomaFAERS: 2US FAERS
1378pseudomembranous colitisFAERS: 2US FAERS
1379AcarodermatitisFAERS: 1US FAERS
1380Accidental exposureFAERS: 1US FAERS
1381Acid fast bacilli infectionFAERS: 1US FAERS
1382Acquired gene mutationFAERS: 1US FAERS
1383Activated partial thromboplastin time shortenedFAERS: 1US FAERS
1384Acute Lung InjuryFAERS: 1US FAERS
1385Acute prerenal failureFAERS: 1US FAERS
1386Acute psychosisFAERS: 1US FAERS
1387Acute tonsillitisFAERS: 1US FAERS
1388Adrenal massFAERS: 1US FAERS
1389AlbuminuriaFAERS: 1US FAERS
1390Alcohol IntoleranceFAERS: 1US FAERS
1391Alpha 2 globulin increasedFAERS: 1US FAERS
1392Alveolar soft part sarcoma metastaticFAERS: 1US FAERS
1393Amnestic DisorderFAERS: 1US FAERS
1394AmyloidosisFAERS: 1US FAERS
1395Anal erosionFAERS: 1US FAERS
1396Anal fistula infectionFAERS: 1US FAERS
1397Anal sphincter atonyFAERS: 1US FAERS
1398Anal sphincter hypertoniaFAERS: 1US FAERS
1399Anastomotic LeakFAERS: 1US FAERS
1400AneurysmectomyFAERS: 1US FAERS
1401AngiodysplasiaFAERS: 1US FAERS
1402AngiofibromaFAERS: 1US FAERS
1403AngiomyolipomaFAERS: 1US FAERS
1404AnophthalmosFAERS: 1US FAERS
1405AnoxiaFAERS: 1US FAERS
1406Anoxic EncephalopathyFAERS: 1US FAERS
1407Anti-Muellerian hormone level decreasedFAERS: 1US FAERS
1408Anti-platelet antibody positiveFAERS: 1US FAERS
1409Anti-platelet antibodyFAERS: 1US FAERS
1410Anti-thyroid antibody positiveFAERS: 1US FAERS
1411Antibody test positiveFAERS: 1US FAERS
1412Antiendomysial antibody positiveFAERS: 1US FAERS
1413Antiphospholipid SyndromeFAERS: 1US FAERS
1414Antithrombin III decreasedFAERS: 1US FAERS
1415Apallic syndromeFAERS: 1US FAERS
1416Apparent life threatening eventFAERS: 1US FAERS
1417Application site reactionFAERS: 1US FAERS
1418Arterial insufficiencyFAERS: 1US FAERS
1419Arteriosclerotic retinopathyFAERS: 1US FAERS
1420Arteriovenous fistula thrombosisFAERS: 1US FAERS
1421Aspartate aminotransferase abnormalFAERS: 1US FAERS
1422AsphyxiaFAERS: 1US FAERS
1423Astrocytoma, low gradeFAERS: 1US FAERS
1424AtopyFAERS: 1US FAERS
1425Atrial hypertrophyFAERS: 1US FAERS
1426Atypical pneumoniaFAERS: 1US FAERS
1427Audiogram abnormalFAERS: 1US FAERS
1428AuraFAERS: 1US FAERS
1429Autoantibody positiveFAERS: 1US FAERS
1430Autoimmune PancreatitisFAERS: 1US FAERS
1431Autoimmune thrombocytopeniaFAERS: 1US FAERS
1432Axonal neuropathyFAERS: 1US FAERS
1433BabesiosisFAERS: 1US FAERS
1434Bacterial TranslocationFAERS: 1US FAERS
1435Basophil count abnormalFAERS: 1US FAERS
1436Basophil percentage increasedFAERS: 1US FAERS
1437Benign neoplasm of testisFAERS: 1US FAERS
1438Beta-N-acetyl-D-glucosaminidase increasedFAERS: 1US FAERS
1439Bile duct cancer recurrentFAERS: 1US FAERS
1440Bile duct necrosisFAERS: 1US FAERS
1441Biliary sepsisFAERS: 1US FAERS
1442Biopsy lung abnormalFAERS: 1US FAERS
1443Biopsy prostate abnormalFAERS: 1US FAERS
1444Bipolar II disorderFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1445Bladder neck obstructionFAERS: 1US FAERS
1446Bladder painFAERS: 1US FAERS
1447Bladder polypectomyFAERS: 1US FAERS
1448Bladder tamponadeFAERS: 1US FAERS
1449Blood bicarbonate abnormalFAERS: 1US FAERS
1450Blood brain barrier defectFAERS: 1US FAERS
1451Blood bromide increasedFAERS: 1US FAERS
1452Blood cannabinoidsFAERS: 1US FAERS
1453Blood chloride decreasedFAERS: 1US FAERS
1454Blood cholesterolFAERS: 1US FAERS
1455Blood cholinesterase decreasedFAERS: 1US FAERS
1456Blood creatine phosphokinase MBFAERS: 1US FAERS
1457Blood creatine phosphokinase MB increasedFAERS: 1US FAERS
1458Blood electrolytes decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1459Blood fibrinogen increasedFAERS: 1US FAERS
1460Blood folate decreasedFAERS: 1US FAERS
1461Blood immunoglobulin A decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1462Blood immunoglobulin M decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1463Blood osmolarity increasedFAERS: 1US FAERS
1464Blood phosphorus abnormalFAERS: 1US FAERS
1465Blood prolactin increasedFAERS: 1US FAERS
1466Blood sodium abnormalFAERS: 1US FAERS
1467Blood stem cell transplant failureFAERS: 1US FAERS
1468Blood testosterone decreasedFAERS: 1US FAERS
1469Blood uric acid abnormalFAERS: 1US FAERS
1470Blood uric acid decreasedFAERS: 1US FAERS
1471Blood zinc decreasedFAERS: 1US FAERS
1472Body surface area increasedFAERS: 1US FAERS
1473Body temperature fluctuationFAERS: 1US FAERS
1474Bone callus excessiveFAERS: 1US FAERS
1475Bone fistulaFAERS: 1US FAERS
1476Bone marrow transplant rejectionFAERS: 1US FAERS
1477Bone resorption test abnormalFAERS: 1US FAERS
1478Brain AbscessFAERS: 1US FAERS
1479Brain ContusionFAERS: 1US FAERS
1480Brain Stem GliomaFAERS: 1US FAERS
1481Breast adenomaFAERS: 1US FAERS
1482Breast cancer stage IIFAERS: 1US FAERS
1483Breast engorgementFAERS: 1US FAERS
1484Breast fibromaFAERS: 1US FAERS
1485Breast hyperplasiaFAERS: 1US FAERS
1486Breast infectionFAERS: 1US FAERS
1487Breast tendernessFAERS: 1US FAERS
1488Bronchoalveolar LavageFAERS: 1US FAERS
1489BronchopneumopathyFAERS: 1US FAERS
1490Burning feet syndromeFAERS: 1US FAERS
1491Calcium deficiencyFAERS: 1US FAERS
1492Cardiac HypertrophyFAERS: 1US FAERS
1493Cardiac function test abnormalFAERS: 1US FAERS
1494Cardiac neoplasm unspecifiedFAERS: 1US FAERS
1495Cardiac valve vegetationFAERS: 1US FAERS
1496Cardiac ventricular disorderFAERS: 1US FAERS
1497Carotid EndarterectomyFAERS: 1US FAERS
1498Carotid pulse abnormalFAERS: 1US FAERS
1499Cataract operation complicationFAERS: 1US FAERS
1500Catheter related infectionFAERS: 1US FAERS
1501Catheter sepsisFAERS: 1US FAERS
1502Cell DeathFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1503Central line infectionFAERS: 1US FAERS
1504Central nervous system massFAERS: 1US FAERS
1505Cerebral ThrombosisFAERS: 1US FAERS
1506Cerebral hypoperfusionFAERS: 1US FAERS
1507Cerebrospinal fluid retentionFAERS: 1US FAERS
1508Cerebrovascular InsufficiencyFAERS: 1US FAERS
1509Cervical laser therapyFAERS: 1US FAERS
1510Cervicobrachial syndromeFAERS: 1US FAERS
1511Chest wall painFAERS: 1US FAERS
1512ChondromalaciaFAERS: 1US FAERS
1513ChorioamnionitisFAERS: 1US FAERS
1514ChorioretinitisFAERS: 1US FAERS
1515ChoroiditisFAERS: 1US FAERS
1516Chromosomal mutationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1517Chronic Fatigue SyndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1518Chronic gastritisFAERS: 1US FAERS
1519Chronic graft versus host disease in skinFAERS: 1US FAERS
1520ChylothoraxFAERS: 1US FAERS
1521ClonusFAERS: 1US FAERS
1522Coagulation factor V level abnormalFAERS: 1US FAERS
1523Coagulation factor V level decreasedFAERS: 1US FAERS
1524Colostomy infectionFAERS: 1US FAERS
1525Composite LymphomaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1526Compression stockings applicationFAERS: 1US FAERS
1527Congenital anomaly in offspringFAERS: 1US FAERS
1528Congenital varicoceleFAERS: 1US FAERS
1529Conjunctival ulcerFAERS: 1US FAERS
1530ConjunctivochalasisFAERS: 1US FAERS
1531Cor pulmonaleFAERS: 1US FAERS
1532Corneal OpacityFAERS: 1US FAERS
1533Corneal degenerationFAERS: 1US FAERS
1534Coronavirus test positiveFAERS: 1US FAERS
1535Cranial operationFAERS: 1US FAERS
1536CraniosynostosisFAERS: 1US FAERS
1537Creatinine renal clearance increasedFAERS: 1US FAERS
1538Creutzfeldt-Jakob diseaseFAERS: 1US FAERS
1539Critical IllnessFAERS: 1US FAERS
1540Cutis LaxaFAERS: 1US FAERS
1541Cytomegalovirus gastroenteritisFAERS: 1US FAERS
1542Cytotoxic cardiomyopathyFAERS: 1US FAERS
1543Deficiency of bile secretionFAERS: 1US FAERS
1544DeformityFAERS: 1US FAERS
1545Dental prosthesis placementFAERS: 1US FAERS
1546Deoxypyridinoline urine increasedFAERS: 1US FAERS
1547Deposit eyeFAERS: 1US FAERS
1548Diabetic foot infectionFAERS: 1US FAERS
1549Diabetic metabolic decompensationFAERS: 1US FAERS
1550DiapedesisFAERS: 1US FAERS
1551Differential white blood cell count abnormalFAERS: 1US FAERS
1552Diverticular perforationFAERS: 1US FAERS
1553DroolingFAERS: 1US FAERS
1554Drug abuserFAERS: 1US FAERS
1555Drug abuseFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1556Drug administration errorFAERS: 1US FAERS
1557Drug dispensed to wrong patientFAERS: 1US FAERS
1558Drug level above therapeuticFAERS: 1US FAERS
1559Drug screen positiveFAERS: 1US FAERS
1560Dry gangreneFAERS: 1US FAERS
1561Duodenal fistulaFAERS: 1US FAERS
1562Duodenal ulcer perforationFAERS: 1US FAERS
1563DuodenectomyFAERS: 1US FAERS
1564DuodenostomyFAERS: 1US FAERS
1565Eating disorder symptomFAERS: 1US FAERS
1566Economic problemFAERS: 1US FAERS
1567Electrocardiogram QT interval abnormalFAERS: 1US FAERS
1568Electrocardiogram ST-T segment abnormalFAERS: 1US FAERS
1569Electrocardiogram changeFAERS: 1US FAERS
1570Electromechanical dissociationFAERS: 1US FAERS
1571Electrophoresis abnormalFAERS: 1US FAERS
1572Emphysematous bullaFAERS: 1US FAERS
1573Endodontic procedureFAERS: 1US FAERS
1574Endometrial adenocarcinomaFAERS: 1US FAERS
1575EndophthalmitisFAERS: 1US FAERS
1576Endoscopy upper gastrointestinal tract abnormalFAERS: 1US FAERS
1577Enlarged uvulaFAERS: 1US FAERS
1578Enterococcal sepsisFAERS: 1US FAERS
1579Enterococcus test positiveFAERS: 1US FAERS
1580Enterocutaneous FistulaFAERS: 1US FAERS
1581EnuresisFAERS: 1US FAERS
1582Enzyme abnormalityFAERS: 1US FAERS
1583Enzyme level increasedFAERS: 1US FAERS
1584Eosinophil percentage increasedFAERS: 1US FAERS
1585Eosinophilic granulomatosis with polyangiitisFAERS: 1US FAERS
1586EpicondylitisFAERS: 1US FAERS
1587EpidermolysisFAERS: 1US FAERS
1588EpiglottitisFAERS: 1US FAERS
1589EpitheliomaFAERS: 1US FAERS
1590Epstein-Barr virus antigen positiveFAERS: 1US FAERS
1591Epstein-Barr virus test positiveFAERS: 1US FAERS
1592ErythrocyanosisFAERS: 1US FAERS
1593Escherichia urinary tract infectionFAERS: 1US FAERS
1594Eustachian tube disorderFAERS: 1US FAERS
1595ExeresisFAERS: 1US FAERS
1596Exposure to chemical pollutionFAERS: 1US FAERS
1597Extraocular Muscle ParesisFAERS: 1US FAERS
1598ExtravasationFAERS: 1US FAERS
1599Facial wastingFAERS: 1US FAERS
1600Fanconi SyndromeFAERS: 118215707CTD
US FAERS
1601Febrile infectionFAERS: 1US FAERS
1602Fibrodysplasia Ossificans ProgressivaFAERS: 1US FAERS
1603Fixed eruptionFAERS: 1US FAERS
1604Flat affectFAERS: 1US FAERS
1605Foaming at mouthFAERS: 1US FAERS
1606Food aversionFAERS: 1US FAERS
1607Forced expiratory volume abnormalFAERS: 1US FAERS
1608Foreign body aspirationFAERS: 1US FAERS
1609Foreign body in respiratory tractFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1610Foreign body sensation in eyesFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1611Freezing phenomenonFAERS: 1US FAERS
1612Gallop rhythm presentFAERS: 1US FAERS
1613Gastric FistulaFAERS: 1US FAERS
1614Gastric StenosisFAERS: 1US FAERS
1615Gastric pH decreasedFAERS: 1US FAERS
1616Gastric polypectomyFAERS: 1US FAERS
1617Gastrointestinal anastomotic complicationFAERS: 1US FAERS
1618Gastrointestinal angiectasiaFAERS: 1US FAERS
1619Gastrointestinal endoscopic therapyFAERS: 1US FAERS
1620Gastrointestinal erosionFAERS: 1US FAERS
1621Gastrointestinal hypermotilityFAERS: 1US FAERS
1622Gastrointestinal scanFAERS: 1US FAERS
1623Gastrointestinal stoma complicationFAERS: 1US FAERS
1624Gastrointestinal tract adenomaFAERS: 1US FAERS
1625Genital abscessFAERS: 1US FAERS
1626Genital infectionFAERS: 1US FAERS
1627Gingival HyperplasiaFAERS: 1US FAERS
1628Gingival blisterFAERS: 1US FAERS
1629GlossectomyFAERS: 1US FAERS
1630GlycosuriaFAERS: 1US FAERS
1631Graft versus host disease in gastrointestinal tractFAERS: 1US FAERS
1632Graft versus host disease in intestineFAERS: 1US FAERS
1633Granulocyte count increasedFAERS: 1US FAERS
1634Granulocytes abnormalFAERS: 1US FAERS
1635Granulomatous liver diseaseFAERS: 1US FAERS
1636HaematidrosisFAERS: 1US FAERS
1637Hair injuryFAERS: 1US FAERS
1638Head titubationFAERS: 1US FAERS
1639Hepatic InfarctionFAERS: 1US FAERS
1640Hepatic calcificationFAERS: 1US FAERS
1641Hepatic cancer metastaticFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1642Hepatitis B virus test positiveFAERS: 1US FAERS
1643Herpes dermatitisFAERS: 1US FAERS
1644High turnover osteopathyFAERS: 1US FAERS
1645Human papilloma virus test positiveFAERS: 1US FAERS
1646Human polyomavirus infectionFAERS: 1US FAERS
1647HungerFAERS: 1US FAERS
1648HydrophobiaFAERS: 1US FAERS
1649HypercreatinaemiaFAERS: 1US FAERS
1650HypercreatininaemiaFAERS: 1US FAERS
1651HypermetabolismFAERS: 1US FAERS
1652HyperparathyroidismFAERS: 1US FAERS
1653HyperphagiaFAERS: 1US FAERS
1654HypersplenismFAERS: 1US FAERS
1655HypertrichosisFAERS: 1US FAERS
1656Hypocoagulable stateFAERS: 1US FAERS
1657HypomaniaFAERS: 1US FAERS
1658HypoparathyroidismFAERS: 1US FAERS
1659HypopituitarismFAERS: 1US FAERS
1660Idiosyncratic drug reactionFAERS: 1US FAERS
1661IleectomyFAERS: 1US FAERS
1662IleitisFAERS: 1US FAERS
1663ImmobileFAERS: 1US FAERS
1664Impaired quality of lifeFAERS: 1US FAERS
1665Implant site calcificationFAERS: 1US FAERS
1666Implant site inflammationFAERS: 1US FAERS
1667Incorrect route of product administrationFAERS: 1US FAERS
1668Increased viscosity of bronchial secretionFAERS: 1US FAERS
1669Infection in an immunocompromised hostFAERS: 1US FAERS
1670Infectious pleural effusionFAERS: 1US FAERS
1671InfestationFAERS: 1US FAERS
1672Infusion site painFAERS: 1US FAERS
1673Inguinal massFAERS: 1US FAERS
1674Intercapillary glomerulosclerosisFAERS: 1US FAERS
1675Interleukin-2 receptor increasedFAERS: 1US FAERS
1676Internal injuryFAERS: 1US FAERS
1677Intestinal FistulaFAERS: 1US FAERS
1678Intestinal scarringFAERS: 1US FAERS
1679Intra-abdominal fluid collectionFAERS: 1US FAERS
1680Intracardiac massFAERS: 1US FAERS
1681Iodine uptake decreasedFAERS: 1US FAERS
1682Irregular sleep phaseFAERS: 1US FAERS
1683JC virus infectionFAERS: 1US FAERS
1684Janus kinase 2 mutationFAERS: 1US FAERS
1685Joint InstabilityFAERS: 1US FAERS
1686KeratitisFAERS: 1US FAERS
1687Keratosis obturansFAERS: 1US FAERS
1688Klebsiella sepsisFAERS: 1US FAERS
1689Lactose IntoleranceFAERS: 1US FAERS
1690Large intestinal stenosisFAERS: 1US FAERS
1691Large intestine anastomosisFAERS: 1US FAERS
1692Laryngeal neoplasmFAERS: 1US FAERS
1693Laser TherapyFAERS: 1US FAERS
1694Lens dislocationFAERS: 1US FAERS
1695Lesion excisionFAERS: 1US FAERS
1696Leukocyte alkaline phosphatase increasedFAERS: 1US FAERS
1697LeukostasisFAERS: 1US FAERS
1698Libido disorderFAERS: 1US FAERS
1699Limb fractureFAERS: 1US FAERS
1700Limb operationFAERS: 1US FAERS
1701Lip exfoliationFAERS: 1US FAERS
1702LipomaFAERS: 1US FAERS
1703Liposarcoma recurrentFAERS: 1US FAERS
1704Listeria encephalitisFAERS: 1US FAERS
1705Liver sarcoidosisFAERS: 1US FAERS
1706Liver transplant rejectionFAERS: 1US FAERS
1707Lobar PneumoniaFAERS: 1US FAERS
1708Locked-In SyndromeFAERS: 1US FAERS
1709Long QT SyndromeFAERS: 124052561CTD
US FAERS
1710Loss of personal independence in daily activitiesFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1711Low density lipoprotein increasedFAERS: 1US FAERS
1712Lumbosacral plexus lesionFAERS: 1US FAERS
1713Lumbosacral radiculopathyFAERS: 1US FAERS
1714Lupus-like syndromeFAERS: 1US FAERS
1715Lyme DiseaseFAERS: 1US FAERS
1716Lymphangiosis carcinomatosaFAERS: 1US FAERS
1717LymphangitisFAERS: 1US FAERS
1718Lymphatic obstructionFAERS: 1US FAERS
1719Lymphocyte count abnormalFAERS: 1US FAERS
1720Lymphocytic dermatitisFAERS: 1US FAERS
1721LymphohistiocytosisFAERS: 1US FAERS
1722MacroglossiaFAERS: 1US FAERS
1723Macular fibrosisFAERS: 1US FAERS
1724MaculeFAERS: 1US FAERS
1725Malaria antibody test positiveFAERS: 1US FAERS
1726Malignant Fibrous HistiocytomaFAERS: 1US FAERS
1727Malignant ascitesFAERS: 1US FAERS
1728Malignant transformationFAERS: 1US FAERS
1729Mantle cell lymphoma stage IVFAERS: 1US FAERS
1730MarasmusFAERS: 1US FAERS
1731Maternal exposure during deliveryFAERS: 1US FAERS
1732Mediastinal massFAERS: 1US FAERS
1733Medication residue presentFAERS: 1US FAERS
1734MegacolonFAERS: 1US FAERS
1735Megakaryocytes decreasedFAERS: 1US FAERS
1736MegakaryocytesFAERS: 1US FAERS
1737Megaloblasts increasedFAERS: 1US FAERS
1738MeningismFAERS: 1US FAERS
1739Meningitis herpesFAERS: 1US FAERS
1740MeningoceleFAERS: 1US FAERS
1741Mesenteric neoplasmFAERS: 1US FAERS
1742Metabolic alkalosisFAERS: 1US FAERS
1743MetamorphopsiaFAERS: 1US FAERS
1744Metamyelocyte count decreasedFAERS: 1US FAERS
1745Metastases to diaphragmFAERS: 1US FAERS
1746Metastases to thoraxFAERS: 1US FAERS
1747Micrographic skin surgeryFAERS: 1US FAERS
1748Micturition frequency decreasedFAERS: 1US FAERS
1749Milk AllergyFAERS: 1US FAERS
1750Mitral valve disease mixedFAERS: 1US FAERS
1751Mouth cystFAERS: 1US FAERS
1752Mucosal erosionFAERS: 1US FAERS
1753Multi-organ disorderFAERS: 1US FAERS
1754Multifocal micronodular pneumocyte hyperplasiaFAERS: 1US FAERS
1755Multiple PregnancyFAERS: 1US FAERS
1756Muscle necrosisFAERS: 1US FAERS
1757Mycosis FungoidesFAERS: 1US FAERS
1758Myeloblast count increasedFAERS: 1US FAERS
1759Myocardial ruptureFAERS: 1US FAERS
1760Myocardial strainFAERS: 1US FAERS
1761MyoglobinaemiaFAERS: 1US FAERS
1762MyopiaFAERS: 1US FAERS
1763Nail bed disorderFAERS: 1US FAERS
1764Natural killer-cell lymphoblastic lymphomaFAERS: 1US FAERS
1765NephrosclerosisFAERS: 1US FAERS
1766Nephrostomy tube placementFAERS: 1US FAERS
1767Neuralgic AmyotrophyFAERS: 1US FAERS
1768NeuroblastomaFAERS: 1US FAERS
1769NeuroborreliosisFAERS: 1US FAERS
1770NeurodermatitisFAERS: 1US FAERS
1771NeurofibrosarcomaFAERS: 1US FAERS
1772Neutrophil morphology abnormalFAERS: 1US FAERS
1773Neutrophil percentage decreasedFAERS: 1US FAERS
1774No adverse effectFAERS: 1US FAERS
1775Nodular fasciitisFAERS: 1US FAERS
1776Nodule on extremityFAERS: 1US FAERS
1777Noninfective gingivitisFAERS: 1US FAERS
1778Norovirus test positiveFAERS: 1US FAERS
1779Obsessive-Compulsive DisorderFAERS: 1US FAERS
1780Ocular HypertensionFAERS: 1US FAERS
1781Ocular discomfortFAERS: 1US FAERS
1782OligospermiaFAERS: 1US FAERS
1783Omental infarctionFAERS: 1US FAERS
1784OnychalgiaFAERS: 1US FAERS
1785Oral contusionFAERS: 1US FAERS
1786Oral mucosal petechiaeFAERS: 1US FAERS
1787Oromandibular dystoniaFAERS: 1US FAERS
1788Oropharyngeal candidiasisFAERS: 1US FAERS
1789Oropharyngeal spasmFAERS: 1US FAERS
1790Oropharyngeal swellingFAERS: 1US FAERS
1791Osteitis DeformansFAERS: 1US FAERS
1792Osteocalcin increasedFAERS: 1US FAERS
1793OsteomaFAERS: 1US FAERS
1794OsteorrhagiaFAERS: 1US FAERS
1795OsteosclerosisFAERS: 1US FAERS
1796Ovarian adenomaFAERS: 1US FAERS
1797Oxygen supplementationFAERS: 1US FAERS
1798PCO2 increasedFAERS: 1US FAERS
1799Palpable purpuraFAERS: 1US FAERS
1800PancreatectomyFAERS: 1US FAERS
1801Pancreatic CystFAERS: 1US FAERS
1802Pancreatic PseudocystFAERS: 1US FAERS
1803Pancreatic enzyme abnormalityFAERS: 1US FAERS
1804Pancreatic enzymes increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1805Pancreatic leakFAERS: 1US FAERS
1806Pancreatic operationFAERS: 1US FAERS
1807Pancreatic toxicityFAERS: 1US FAERS
1808Pancreatobiliary sphincterotomyFAERS: 1US FAERS
1809Paranasal cystFAERS: 1US FAERS
1810Parasite stool test positiveFAERS: 1US FAERS
1811Parenteral NutritionFAERS: 1US FAERS
1812Paternal exposure before pregnancyFAERS: 1US FAERS
1813Paternal exposure timing unspecifiedFAERS: 1US FAERS
1814Pelvic InfectionFAERS: 1US FAERS
1815Pelvic abscessFAERS: 1US FAERS
1816PemphigusFAERS: 1US FAERS
1817Peptic UlcerFAERS: 1US FAERS
1818Pericardial CystFAERS: 1US FAERS
1819Perineal infectionFAERS: 1US FAERS
1820Perineal painFAERS: 1US FAERS
1821Periorbital disorderFAERS: 1US FAERS
1822Perirectal abscessFAERS: 1US FAERS
1823Peritoneal DialysisFAERS: 1US FAERS
1824Peritoneal InfectionFAERS: 1US FAERS
1825Peritoneal cystFAERS: 1US FAERS
1826Peritoneal fluid analysis abnormalFAERS: 1US FAERS
1827Peritoneal perforationFAERS: 1US FAERS
1828Persistent depressive disorderFAERS: 1US FAERS
1829PhotodermatosisFAERS: 1US FAERS
1830Physical abuseFAERS: 1US FAERS
1831Physical disabilityFAERS: 1US FAERS
1832PiloerectionFAERS: 1US FAERS
1833Plantar erythemaFAERS: 1US FAERS
1834Plasmin inhibitor decreasedFAERS: 1US FAERS
1835Plasminogen decreasedFAERS: 1US FAERS
1836Plasmodium vivax infectionFAERS: 1US FAERS
1837Platelet function test abnormalFAERS: 1US FAERS
1838PleurodesisFAERS: 1US FAERS
1839PneumobiliaFAERS: 1US FAERS
1840PneumocephalusFAERS: 1US FAERS
1841PneumoperitoneumFAERS: 1US FAERS
1842PoliomyelitisFAERS: 1US FAERS
1843PolyhydramniosFAERS: 1US FAERS
1844Poor personal hygieneFAERS: 1US FAERS
1845Portal fibrosisFAERS: 1US FAERS
1846Positron emission tomogram abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1847Post procedural fistulaFAERS: 1US FAERS
1848Post-Traumatic HeadacheFAERS: 1US FAERS
1849Post-Traumatic Stress DisorderFAERS: 1US FAERS
1850Post-traumatic neck syndromeFAERS: 1US FAERS
1851Posterior reversible encephalopathy syndromeFAERS: 1US FAERS
1852Postoperative adhesionFAERS: 1US FAERS
1853Postoperative wound complicationFAERS: 1US FAERS
1854Pre-existing condition improvedFAERS: 1US FAERS
1855Precancerous cells presentFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1856Pregnancy with contraceptive deviceFAERS: 1US FAERS
1857Premature MenopauseFAERS: 1US FAERS
1858Prerenal failureFAERS: 1US FAERS
1859Procalcitonin increasedFAERS: 1US FAERS
1860Procedural hypotensionFAERS: 1US FAERS
1861Procedural site reactionFAERS: 1US FAERS
1862Product availability issueFAERS: 1US FAERS
1863Product blister packaging issueFAERS: 1US FAERS
1864Product package associated injuryFAERS: 1US FAERS
1865Product packaging difficult to openFAERS: 1US FAERS
1866Product size issueFAERS: 1US FAERS
1867Product solubility abnormalFAERS: 1US FAERS
1868Product taste abnormalFAERS: 1US FAERS
1869Prostate examination abnormalFAERS: 1US FAERS
1870ProstatismFAERS: 1US FAERS
1871Protein C DeficiencyFAERS: 1US FAERS
1872Protein total abnormalFAERS: 1US FAERS
1873Prothrombin time ratio decreasedFAERS: 1US FAERS
1874Prothrombin time ratio increasedFAERS: 1US FAERS
1875Pseudomonal sepsisFAERS: 1US FAERS
1876PsittacosisFAERS: 1US FAERS
1877PterygiumFAERS: 1US FAERS
1878Pulmonary FistulaFAERS: 1US FAERS
1879Pulmonary InfarctionFAERS: 1US FAERS
1880Pulmonary Valve StenosisFAERS: 1US FAERS
1881Pulmonary microemboliFAERS: 1US FAERS
1882Pulmonary necrosisFAERS: 1US FAERS
1883Pulmonary tuberculomaFAERS: 1US FAERS
1884Pulmonary vascular disorderFAERS: 1US FAERS
1885Pulmonary venous thrombosisFAERS: 1US FAERS
1886Purpura FulminansFAERS: 1US FAERS
1887PurulenceFAERS: 1US FAERS
1888PyelocaliectasisFAERS: 1US FAERS
1889Pyogenic granulomaFAERS: 1US FAERS
1890Pyridinoline urine increasedFAERS: 1US FAERS
1891Radial nerve palsyFAERS: 1US FAERS
1892Radiation injuryFAERS: 1US FAERS
1893Radiation proctitisFAERS: 1US FAERS
1894Radical prostatectomyFAERS: 1US FAERS
1895Rebound effectFAERS: 1US FAERS
1896Rectal tenesmusFAERS: 1US FAERS
1897Red blood cell schistocytes presentFAERS: 1US FAERS
1898Red man syndromeFAERS: 1US FAERS
1899Refractory cytopenia with unilineage dysplasiaFAERS: 1US FAERS
1900Rehabilitation therapyFAERS: 1US FAERS
1901Renal Artery StenosisFAERS: 1US FAERS
1902Renal cell carcinoma recurrentFAERS: 1US FAERS
1903Renal dysplasiaFAERS: 1US FAERS
1904Renal lymphoceleFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1905Respiratory syncytial virus test positiveFAERS: 1US FAERS
1906Respiratory tract infection fungalFAERS: 1US FAERS
1907Retinal aneurysmFAERS: 1US FAERS
1908Retinal artery embolismFAERS: 1US FAERS
1909Retinal pigment epitheliopathyFAERS: 1US FAERS
1910Retinal vascular thrombosisFAERS: 1US FAERS
1911RetinitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1912Retroperitoneal lymphadenopathyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1913Reversible cerebral vasoconstriction syndromeFAERS: 1US FAERS
1914Rheumatic Heart DiseaseFAERS: 1US FAERS
1915RhinoscleromaFAERS: 1US FAERS
1916RhonchiFAERS: 1US FAERS
1917Right Ventricular HypertrophyFAERS: 1US FAERS
1918Salivary gland painFAERS: 1US FAERS
1919Sciatic Nerve PalsyFAERS: 1US FAERS
1920Scleral pigmentationFAERS: 1US FAERS
1921ScleremaFAERS: 1US FAERS
1922SclerotherapyFAERS: 1US FAERS
1923Scoliosis surgeryFAERS: 1US FAERS
1924Scrotal massFAERS: 1US FAERS
1925Scrub TyphusFAERS: 1US FAERS
1926Semen abnormalFAERS: 1US FAERS
1927Senile dementiaFAERS: 1US FAERS
1928Sensitivity to weather changeFAERS: 1US FAERS
1929Septic embolusFAERS: 1US FAERS
1930Severe Acute Respiratory SyndromeFAERS: 1US FAERS
1931Shortened cervixFAERS: 1US FAERS
1932Shoulder PainFAERS: 1US FAERS
1933Sight disabilityFAERS: 1US FAERS
1934Sinus cancer metastaticFAERS: 1US FAERS
1935Sinus painFAERS: 1US FAERS
1936Sinus rhythmFAERS: 1US FAERS
1937Skin WrinklingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1938Skin discomfortFAERS: 1US FAERS
1939Sleep disorder due to general medical condition, insomnia typeFAERS: 1US FAERS
1940Slow response to stimuliFAERS: 1US FAERS
1941Slow speechFAERS: 1US FAERS
1942Small cell lung cancer recurrentFAERS: 1US FAERS
1943SmallpoxFAERS: 1US FAERS
1944SnoringFAERS: 1US FAERS
1945Sodium retentionFAERS: 1US FAERS
1946Soft tissue swellingFAERS: 1US FAERS
1947Spermatozoa progressive motility decreasedFAERS: 1US FAERS
1948Spinal column injuryFAERS: 1US FAERS
1949Splenic abscessFAERS: 1US FAERS
1950Sputum culture positiveFAERS: 1US FAERS
1951Squamous cell carcinoma of lungFAERS: 1US FAERS
1952Staphylococcal osteomyelitisFAERS: 1US FAERS
1953Staphylococcus test positiveFAERS: 1US FAERS
1954Stasis dermatitisFAERS: 1US FAERS
1955StrabismusFAERS: 1US FAERS
1956Streptococcus testFAERS: 1US FAERS
1957Streptococcus test positiveFAERS: 1US FAERS
1958StrongyloidiasisFAERS: 1US FAERS
1959Subcutaneous EmphysemaFAERS: 1US FAERS
1960SubileusFAERS: 1US FAERS
1961Submandibular massFAERS: 1US FAERS
1962Sudden Visual LossFAERS: 1US FAERS
1963Suicide threatFAERS: 1US FAERS
1964SuperinfectionFAERS: 1US FAERS
1965Suspected counterfeit productFAERS: 1US FAERS
1966Suture related complicationFAERS: 1US FAERS
1967Suture ruptureFAERS: 1US FAERS
1968Swelling of eyelidFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
1969SyringomyeliaFAERS: 1US FAERS
1970Systemic lupus erythematosus rashFAERS: 1US FAERS
1971T-Cell LymphomaFAERS: 1US FAERS
1972Tablet physical issueFAERS: 1US FAERS
1973Testicular seminoma (pure) stage IIFAERS: 1US FAERS
1974TetanyFAERS: 1US FAERS
1975Therapy partial responderFAERS: 1US FAERS
1976ThoracotomyFAERS: 1US FAERS
1977Thrombocytopenic purpuraFAERS: 1US FAERS
1978Thymic cancer metastaticFAERS: 1US FAERS
1979Thyroglobulin increasedFAERS: 1US FAERS
1980Thyroid hormones increasedFAERS: 1US FAERS
1981Toe operationFAERS: 1US FAERS
1982Tongue spasmFAERS: 1US FAERS
1983Total lung capacity abnormalFAERS: 1US FAERS
1984Total lung capacity increasedFAERS: 1US FAERS
1985Toxic Shock SyndromeFAERS: 1US FAERS
1986Tracheal dilatationFAERS: 1US FAERS
1987Tracheobronchial dyskinesiaFAERS: 1US FAERS
1988Transfusion-Related Acute Lung InjuryFAERS: 1US FAERS
1989Traumatic liver injuryFAERS: 1US FAERS
1990TrichodyniaFAERS: 1US FAERS
1991TrichorrhexisFAERS: 1US FAERS
1992Tryptase increasedFAERS: 1US FAERS
1993Tuberous SclerosisFAERS: 1US FAERS
1994Tympanic Membrane PerforationFAERS: 1US FAERS
1995Ultrasound scan abnormalFAERS: 1US FAERS
1996Umbilical herniaFAERS: 1US FAERS
1997Upper airway obstructionFAERS: 1US FAERS
1998Upper respiratory tract congestionFAERS: 1US FAERS
1999Urate nephropathyFAERS: 1US FAERS
2000UreterectomyFAERS: 1US FAERS
2001UreteritisFAERS: 1US FAERS
2002UreterolithiasisFAERS: 1US FAERS
2003Urethral ObstructionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
2004Urinary sediment abnormalFAERS: 1US FAERS
2005Urinary tract inflammationFAERS: 1US FAERS
2006Urine calcium decreasedFAERS: 1US FAERS
2007Urine cytology abnormalFAERS: 1US FAERS
2008Uterine PolypFAERS: 1US FAERS
2009Uterine atrophyFAERS: 1US FAERS
2010Uterine contractions during pregnancyFAERS: 1US FAERS
2011Uterine inflammationFAERS: 1US FAERS
2012Vaginal lesionFAERS: 1US FAERS
2013Vagus nerve paralysisFAERS: 1US FAERS
2014Varicella Zoster Virus InfectionFAERS: 1US FAERS
2015Vascular bypass graftFAERS: 1US FAERS
2016Vascular compressionFAERS: 1US FAERS
2017Vascular graft complicationFAERS: 1US FAERS
2018Vascular insufficiencyFAERS: 1US FAERS
2019VasospasmFAERS: 1US FAERS
2020Venoocclusive diseaseFAERS: 1US FAERS
2021Venous occlusionFAERS: 1US FAERS
2022Venous stenosisFAERS: 1US FAERS
2023Ventilation/perfusion scan abnormalFAERS: 1US FAERS
2024Ventricular failureFAERS: 1US FAERS
2025Vertebral lesionFAERS: 1US FAERS
2026VertebroplastyFAERS: 1US FAERS
2027Violence-related symptomFAERS: 1US FAERS
2028Viral myocarditisFAERS: 1US FAERS
2029Viral test positiveFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
2030Vitamin D DeficiencyFAERS: 1US FAERS
2031VitritisFAERS: 1US FAERS
2032Vocal Cord DysfunctionFAERS: 1US FAERS
2033Von Willebrand's factor multimers abnormalFAERS: 1US FAERS
2034Vulvovaginal discomfortFAERS: 1US FAERS
2035Vulvovaginal swellingFAERS: 1US FAERS
2036Waist circumference decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
2037Waist circumference increasedFAERS: 1US FAERS
2038Weaning failureFAERS: 1US FAERS
2039Wheelchair userFAERS: 1US FAERS
2040Wolff-Parkinson-White SyndromeFAERS: 1US FAERS
2041Wound dehiscenceFAERS: 1US FAERS
2042Wrong doseFAERS: 1US FAERS
2043Wrong drug administeredFAERS: 1US FAERS
2044XerodermaFAERS: 1US FAERS
2045ZygomycosisFAERS: 1US FAERS
2046angiogramFAERS: 1US FAERS
2047gliosarcomaFAERS: 1US FAERS
2048leiomyosarcomaFAERS: 1US FAERS
2049ovarian neoplasmFAERS: 1US FAERS
2050prostatitisFAERS: 1US FAERS
2051synovial sarcomaFAERS: 1US FAERS
2052Abnormalities, Drug-Induced31278918CTD
2053Anemia15160343CTD
2054Anxiety Disorders17405756CTD
2055Blister ruptureCanada Vigilance: 1Canada Vigilance
2056Bone neoplasms15867366CTD
2057Brain Infarction18409077CTD
2058Chemical and Drug Induced Liver Injury17980129
23994742
24014644
CTD
2059Craniofacial Abnormalities18322153CTD
2060Cytokine Release SyndromeCanada Vigilance: 1Canada Vigilance
2061Diarrhea17405756
18409077
18608866
CTD
2062Edema19703484
19849764
CTD
2063Exanthema11549802CTD
2064Exposure via body fluidCanada Vigilance: 2Canada Vigilance
2065Fibromatosis, Aggressive17453242CTD
2066Food AllergyCanada Vigilance: 1Canada Vigilance
2067Gastrointestinal Neoplasms12401901
15764042
19662540
CTD
2068Gastrointestinal Stromal Tumors

View details

CTD
2069Heart Diseases21937741CTD
2070Heart failure22641616
28347583
CTD
2071HyperreflexiaCanada Vigilance: 1Canada Vigilance
2072Hypocalcemia17040091CTD
2073Hypophosphatemia18215707CTD
2074Intracranial massCanada Vigilance: 1Canada Vigilance
2075LazinessCanada Vigilance: 1Canada Vigilance
2076Leukemia, Experimental18358458CTD
2077Lichenoid Eruptions15764042CTD
2078Liver Cirrhosis, Experimental16596278CTD
2079Liver Cirrhosis21316382CTD
2080Liver Failure, Acute18161937
18362995
19662540
CTD
2081Liver diseases17364993CTD
2082Lung Diseases, Interstitial29720568CTD
2083Lung Neoplasms29730267CTD
2084Lysosomal Storage Diseases28551711CTD
2085Muscular Dystrophy, Animal19289603CTD
2086Myocardial fibrosisCanada Vigilance: 1Canada Vigilance
2087Neoplasm Metastasis15867366
29730267
CTD
2088Neoplasms, Hormone-Dependent17614352CTD
2089Neoplasms21295132CTD
2090Osteopetrosis21586300CTD
2091Peripheral Nervous System Diseases19849764CTD
2092Pharyngeal swellingCanada Vigilance: 2Canada Vigilance
2093Product complaintCanada Vigilance: 3Canada Vigilance
2094Prostatic Neoplasms16288076CTD
2095Recurrence25605917CTD
2096Renal Insufficiency18215707CTD
2097Stomach Neoplasms15786421CTD
2098Therapeutic product effect decreasedCanada Vigilance: 1Canada Vigilance
2099Thrombocythemia, Essential16682291CTD
2100Upper motor neurone lesionCanada Vigilance: 1Canada Vigilance
2101Ventricular Dysfunction, Left22641616CTD
2102leukemia24240679CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120141

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.